Results 1-584 of 584 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12024Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT studyPiscaglia, Fabio; Ikeda, Kenji; ANN-LII CHENG ; Kudo, Masatoshi; Ikeda, Masafumi; Breder, Valery; Ryoo, Baek-Yeol; Mody, Kalgi; Ren, Min; Ramji, Zahra; Sung, Max WCancer2
22024Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 studyYau, Thomas; Kaseb, Ahmed; ANN-LII CHENG ; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Milwee, Steven; Wang, Zhong; Curran, Dominic; Kelley, Robin Kate; Rimassa, LorenzaThe lancet. Gastroenterology & hepatology3
32024Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinomaSangro, B; Chan, S L; Kelley, R K; Lau, G; Kudo, M; Sukeepaisarnjaroen, W; Yarchoan, M; De Toni, E N; Furuse, J; Kang, Y K; Galle, P R; Rimassa, L; Heurgué, A; Tam, V C; Van Dao, T; Thungappa, S C; Breder, V; Ostapenko, Y; Reig, M; Makowsky, M; Paskow, M J; Gupta, C; Kurland, J F; Negro, A; Abou-Alfa, G K; ANN-LII CHENG Annals of oncology : official journal of the European Society for Medical Oncology
42024Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab eraWEI-LI MA ; RUEY-LONG HONG ; PEI-JEN LOU ; MING YAO ; SHANG-JU WU ; CHUNG-WU LIN ; CHUN-WEI WANG ; Chang, Chin-Hao; ANN-LII CHENG ; SUNG-HSIN KUO Cancer medicine00
52024Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical TrialWEI-WU CHEN ; Dai, Ming-Shen; Tseng, Ling-Ming; Chen, Shin-Cheh; Chao, Tsu-Yi; Chao, Ta-Chung; Chang, Yuan-Ching; Chiu, Chang-Fang; Liu, Chien-Ting; Lin, Ching-Hung; Liu, Chun-Yu; YA-FANG CHEN ; DWANG-YING CHANG ; Yu, Jyh-Cherng; Rau, Kun-Ming; Hsieh, Yao-Yu; Shen, Shih-Che; Huang, Shu-Min; ANN-LII CHENG ; YEN-SHEN LU JAMA oncology1
62023Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)Abou-Alfa, Ghassan K; Lau, George; Kudo, Masatoshi; Chan, Stephen L; Kelley, Robin Kate; Furuse, Junji; Sukeepaisarnjaroen, Wattana; Kang, Yoon Koo; Dao, Tu Van; De Toni, Enrico N; Rimassa, Lorenza; Breder, Valeriy; Vasilyev, Alexander; Heurgué, Alexandra; Tam, Vincent C; Mody, Kabir; Thungappa, Satheesh Chiradoni; Ostapenko, Yurii; Yau, Thomas; Azevedo, Sergio; Varela, María; ANN-LII CHENG ; Qin, Shukui; Galle, Peter R; Ali, Sajid; Gupta, Charu; Makowsky, Mallory; Kurland, John F; Negro, Alejandra; Sangro, BrunoFuture oncology (London, England)3
72023Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trialLlovet, Josep M; Kudo, Masatoshi; Merle, Philippe; Meyer, Tim; Qin, Shukui; Ikeda, Masafumi; Xu, Ruocai; Edeline, Julien; Ryoo, Baek-Yeol; Ren, Zhenggang; Masi, Gianluca; Kwiatkowski, Mariusz; Lim, Ho Yeong; Kim, Jee Hyun; Breder, Valeriy; Kumada, Hiromitsu; ANN-LII CHENG ; Galle, Peter R; Kaneko, Shuichi; Wang, Anran; Mody, Kalgi; Dutcus, Corina; Dubrovsky, Leonid; Siegel, Abby B; Finn, Richard SThe Lancet. Oncology24
82023Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 StudyKudo, Masatoshi; Finn, Richard S; ANN-LII CHENG ; Zhu, Andrew X; Ducreux, Michel; Galle, Peter R; Sakamoto, Naoya; Kato, Naoya; Nakano, Michitaka; Jia, Jing; Vogel, ArndtLiver cancer2
92023Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 studyQin, Shukui; Chan, Stephen L; Gu, Shanzhi; Bai, Yuxian; Ren, Zhenggang; Lin, Xiaoyan; Chen, Zhendong; Jia, Weidong; Jin, Yongdong; Guo, Yabing; Hu, Xiaohua; Meng, Zhiqiang; Liang, Jun; Cheng, Ying; Xiong, Jianping; Ren, Hong; Yang, Fang; Li, Wei; Chen, Yajin; Zeng, Yong; Sultanbaev, Alexander; Pazgan-Simon, Monika; Pisetska, Margaryta; Melisi, Davide; Ponomarenko, Dmitriy; Osypchuk, Yurii; Sinielnikov, Ivan; Yang, Tsai-Sheng; Liang, Xiao; Chen, Chunxia; Wang, Linna; ANN-LII CHENG ; Kaseb, Ahmed; Vogel, Arndt; CHIUN HSU Lancet (London, England)8316
102023Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsDE-RUI HUANG ; BIN-CHI LIAO ; Hsu, Wei-Hsun; CHING-YAO YANG ; YEN-TING LIN ; SHANG-GIN WU ; TZU-HSIU TSAI ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; ANN-LII CHENG ; YING-CHUN SHEN Oncology
112023Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 TrialMerle, Philippe; Kudo, Masatoshi; Edeline, Julien; Bouattour, Mohamed; ANN-LII CHENG ; Chan, Stephen L; Yau, Thomas; Garrido, Marcelo; Knox, Jennifer; Daniele, Bruno; Breder, Valeriy; Lim, Ho Yeong; Ogasawara, Sadahisa; Cattan, Stéphane; Chao, Yee; Siegel, Abby B; Martinez-Forero, Iván; Wei, Ziwen; Liu, Chih-Chin; Finn, Richard SLiver cancer32
122023IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III StudyKudo, Masatoshi; Finn, Richard S; Galle, Peter R; Zhu, Andrew X; Ducreux, Michel; ANN-LII CHENG ; Ikeda, Masafumi; Tsuchiya, Kaoru; Aoki, Ken-Ichi; Jia, Jing; Lencioni, RiccardoLiver cancer64
132023Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomaBANG-BIN CHEN ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH ; TSUNG-HAO LIU ; YING-CHUN SHEN ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO European radiology2013
142023Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell CytotoxicityCHIAO-LING TSAI ; Yang, Po-Sheng; FENG-MING HSU ; ANN-LII CHENG ; Yu, Wan-Ni; CHIA-HSIEN CHENG Journal of clinical and translational hepatology21
152023Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerWEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU Breast cancer research and treatment00
162023Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphomaCHANG-TSU YUAN ; ANN-LII CHENG ; HSIN-AN HOU Virchows Archiv : an international journal of pathology00
172023Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinomaZHONG-ZHE LIN ; Hu, Mickey C-T; CHIUN HSU ; YAO-MING WU ; YEN-SHEN LU ; Ho, Ja-An Annie; Shiou-Hwei Yeh ; PEI-JER CHEN ; ANN-LII CHENG Cancer letters11
182023Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian WomenCHING-HUNG LIN ; Zahid, Muhammad; WEN-HUNG KUO ; Hu, Fu-Chang; MING-YANG WANG ; I-CHUN CHEN ; Beseler, Cheryl L; Mondal, Bodhisattwa; YEN-SHEN LU ; Rogan, Eleanor G; ANN-LII CHENG Cancer prevention research (Philadelphia, Pa.)00
192023Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signallingYU-CHIEH TSAI ; Wang, Tzu-Yin; Hsu, Chia-Lang; WEI-CHOU LIN ; Chen, Jyun-Yu; Li, Jia-Hua; YEONG-SHIAU PU ; ANN-LII CHENG ; CHIA-HSIEN CHENG ; SHENG-FANG SU British journal of cancer74
202023Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus BevacizumabCHIUN HSU ; Ducreux, Michel; Zhu, Andrew X; Qin, Shukui; Ikeda, Masafumi; Kim, Tae-You; Galle, Peter R; Finn, Richard S; Chen, Ethan; Ma, Ning; Hu, Youyou; Li, Lindong; ANN-LII CHENG Liver cancer10
212023Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour locationKasper, Stefan; Foch, Caroline; Esser, Regina; Lamy, Francois-Xavier; Zhang, Aimar; ANN-LII CHENG ; Rouyer, Magali; Brodowicz, Thomas; Zielinski, ChristophEuropean journal of cancer (Oxford, England : 1990)01
222023Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 TrialRen, Zhenggang; Ducreux, Michel; Abou-Alfa, Ghassan K; Merle, Philippe; Fang, Weijia; Edeline, Julien; Li, Zhiwei; Wu, Lihua; Assenat, Eric; Hu, Sheng; Rimassa, Lorenza; Zhang, Tao; Blanc, Jean-Frédéric; Pan, Hongming; Ross, Paul; Yen, Chia-Jui; Tran, Albert; Shao, Guoliang; Bouattour, Mohamed; Chen, Yajin; Meyer, Tim; Hou, Jinlin; Tougeron, David; Bai, Yuxian; Hou, Ming-Mo; Meng, Zhiqiang; Wu, John; Li, Vincent; Chica-Duque, Sandra; ANN-LII CHENG Liver cancer1010
232023Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinomaHUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN Breast cancer research : BCR10
242023Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT studyKudo, Masatoshi; Finn, Richard S; Qin, Shukui; Han, Kwang-Hyub; Ikeda, Kenji; ANN-LII CHENG ; Vogel, Arndt; Tovoli, Francesco; Ueshima, Kazuomi; Aikata, Hiroshi; López, Carlos López; Pracht, Marc; Meng, Zhiqiang; Daniele, Bruno; Park, Joong-Won; Palmer, Daniel; Tamai, Toshiyuki; Saito, Kenichi; Dutcus, Corina E; Lencioni, RiccardoJournal of hepatology106
252023Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancerKUO-HSING CHEN ; CHIA-LANG HSU ; Su, Yu-Li; CHANG-TSU YUAN ; LIANG-IN LIN ; JIA-HUEI TSAI ; YI-HSIN LIANG ; ANN-LII CHENG ; KUN-HUEI YEH British journal of cancer00
262022A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and LeiomyosarcomaWEI-WU CHEN ; CHIA-LANG HSU ; RUEY-LONG HONG ; JEN-CHIEH LEE ; Chang, Koping; CHIH-WEI YU ; Chen, San-Chi; JHE-CYUAN GUO ; Chen, Mei-Lu; Hsu, Meng-Chi; Kung, Ting-Fang; ANN-LII CHENG ; Yen, Chueh-ChuanClinical cancer research : an official journal of the American Association for Cancer Research66
272022First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphomaMing Yao; Shu-Lang Liao; Chung-Wu Lin; Cheng-Ping Wang; WEI-LI MA ; Yi-Hsuan Wei; Jyh-Ming Liou; I-Jong Wang; ANN-LII CHENG ; SUNG-HSIN KUO eJHaem0
282022Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature reviewGraham, Jeffrey; Vogel, Arndt; ANN-LII CHENG ; Bjarnason, Georg A; Neal, Joel WCancer treatment reviews22
292022Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatmentChen, Ching-Tso; Feng, Yin-Hsun; Yen, Chia-Jui; Chen, San-Chi; Lin, Yun-Tzu; LI-CHUN LU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO Hepatology international1414
302022Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and TaiwanWEI-WU CHEN ; Chiang, Ruru Chun-Ju; Le Cesne, Alex; Hsieh, Yu-Chun; Italiano, Antoine; Yang, Ya-Wen; Penel, Nicolas; WEN-CHUNG LEE ; Bompas, Emmanuelle; Valentin, Thibaud; Anract, Philippe; Firmin, Nelly; Duffaud, Florence; ANN-LII CHENG ; Ducimetiere, Francoise; KIN-WEI CHAN ; Blay, Jean-YvesCancer32
312022Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National StudyChen, Ching-Tso; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO Anticancer research00
322022Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trialKelley, Robin Kate; Rimassa, Lorenza; ANN-LII CHENG ; Kaseb, Ahmed; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Banerjee, Kamalika; Hazra, Saswati; Fawcett, Jonathan; Yau, ThomasThe Lancet. Oncology227185
332022Immune checkpoint inhibitors for hepatocellular carcinoma - A game changer in treatment landscapeTSUNG-HAO LIU ; YING-CHUN SHEN ; ANN-LII CHENG Journal of the Formosan Medical Association = Taiwan yi zhi32
342022Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapyTA-CHEN HUANG ; Liang C.-W.; Li Y.-I.; GUO, JHE-CYUAN ; CHIA-CHI LIN ; Chen Y.-J.; ANN-LII CHENG ; CHIH-HUNG HSU Journal of Cancer Research and Clinical Oncology22
352022Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 TrialVerset, Gontran; Borbath, Ivan; Karwal, Mark; Verslype, Chris; Van Vlierberghe, Hans; Kardosh, Adel; Zagonel, Vittorina; Stal, Per; Sarker, Debashis; Palmer, Daniel H; Vogel, Arndt; Edeline, Julien; Cattan, Stephane; Kudo, Masatoshi; ANN-LII CHENG ; Ogasawara, Sadahisa; Daniele, Bruno; Chan, Stephen L; Knox, Jennifer J; Qin, Shukui; Siegel, Abby B; Chisamore, Michael; Hatogai, Ken; Wang, Anran; Finn, Richard S; Zhu, Andrew XClinical cancer research : an official journal of the American Association for Cancer Research3727
362022Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinomaYU-YUN SHAO ; Chen, Pai-Sheng; LIANG-IN LIN ; Lee, Bin-Shyun; Ling, Andrew; ANN-LII CHENG ; CHIUN HSU ; DA-LIANG OU British journal of cancer1010
372022Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trialFreemantle, Nick; Mollon, Patrick; Meyer, Tim; ANN-LII CHENG ; El-Khoueiry, Anthony B; Kelley, Robin K; Baron, Ari D; Benzaghou, Fawzi; Mangeshkar, Milan; Abou-Alfa, Ghassan KEuropean journal of cancer (Oxford, England : 1990)21
382022B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell CarcinomaJHE-CYUAN GUO ; Hsu, Chia-Lang; YEN-LIN HUANG ; CHIA-CHI LIN ; TA-CHEN HUANG ; Wu, I-Chen; Lin, Chen-Yuan; Lien, Ming-Yu; HUNG-YANG KUO ; ANN-LII CHENG ; CHIH-HUNG HSU Frontiers in oncology21
392022Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenibKudo, Masatoshi; Finn, Richard S; Edeline, Julien; Cattan, Stéphane; Ogasawara, Sadahisa; Palmer, Daniel H; Verslype, Chris; Zagonel, Vittorina; Fartoux, Laetitia; Vogel, Arndt; Sarker, Debashis; Verset, Gontran; Chan, Stephen L; Knox, Jennifer; Daniele, Bruno; Yau, Thomas; Gurary, Ellen B; Siegel, Abby B; Wang, Anran; ANN-LII CHENG ; Zhu, Andrew XEuropean journal of cancer (Oxford, England : 1990)4635
402022Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trialEl-Khoueiry, Anthony B; Meyer, Tim; ANN-LII CHENG ; Rimassa, Lorenza; Sen, Suvajit; Milwee, Steven; Kelley, Robin Kate; Abou-Alfa, Ghassan KBMC cancer99
412022Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyLau, George; Yu, Ming-Lung; Wong, Grace; Thompson, Alexander; Ghazinian, Hasmik; Hou, Jin-Lin; Piratvisuth, Teerha; Jia, Ji-Dong; Mizokami, Masashi; Cheng, Gregory; Chen, Guo-Feng; Liu, Zhen-Wen; Baatarkhuu, Oidov; ANN-LII CHENG ; Ng, Woon Leung; Lau, Patrick; Mok, Tony; Chang, Jer-Ming; Hamid, Saeed; Dokmeci, A Kadir; Gani, Rino A; Payawal, Diana A; Chow, Pierce; Park, Joong-Won; Strasser, Simone I; Mohamed, Rosmawaiti; Win, Khin Maung; Tanwandee, Tawesak; Sarin, Shiv Kumar; Omata, MasaoHepatology international00
422022Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinomaANN-LII CHENG ; Qin, Shukui; Ikeda, Masafumi; Galle, Peter R; Ducreux, Michel; Kim, Tae-You; Lim, Ho Yeong; Kudo, Masatoshi; Breder, Valeriy; Merle, Philippe; Kaseb, Ahmed O; Li, Daneng; Verret, Wendy; Ma, Ning; Nicholas, Alan; Wang, Yifan; Li, Lindong; Zhu, Andrew X; Finn, Richard SJournal of hepatology582463
432022Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinomaYU-YUN SHAO ; HUNG-YANG KUO ; YUNG-MING JENG ; YAO-MING WU ; HSIU-PO WANG ; CHIUN HSU ; CHIH-HUNG HSU ; Hsu, Hey-Chi; ANN-LII CHENG ; ZHONG-ZHE LIN BMC cancer33
442022Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue LymphomaSUNG-HSIN KUO ; KUN-HUEI YEH ; CHUNG-WU LIN ; JYH-MING LIOU ; MING-SHIANG WU ; Chen, Li-Tzong; ANN-LII CHENG Cancers98
452022Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular CarcinomaRimassa, Lorenza; Kelley, Robin Kate; Meyer, Tim; Ryoo, Baek-Yeol; Merle, Philippe; Park, Joong-Won; Blanc, Jean-Frederic; Lim, Ho Yeong; Tran, Albert; Chan, Yi-Wah; McAdam, Paul; Wang, Evelyn; ANN-LII CHENG ; El-Khoueiry, Anthony B; Abou-Alfa, Ghassan KLiver cancer1514
462022Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialYau, Thomas; Park, Joong-Won; Finn, Richard S; ANN-LII CHENG ; Mathurin, Philippe; Edeline, Julien; Kudo, Masatoshi; Harding, James J; Merle, Philippe; Rosmorduc, Olivier; Wyrwicz, Lucjan; Schott, Eckart; Choo, Su Pin; Kelley, Robin Kate; Sieghart, Wolfgang; Assenat, Eric; Zaucha, Renata; Furuse, Junji; Abou-Alfa, Ghassan K; El-Khoueiry, Anthony B; Melero, Ignacio; Begic, Damir; Chen, Gong; Neely, Jaclyn; Wisniewski, Tami; Tschaika, Marina; Sangro, BrunoThe Lancet. Oncology510433
472022Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinomaJHE-CYUAN GUO ; CHIA-CHI LIN ; Hsu, Chia-Lang; TA-CHEN HUANG ; HUNG-YANG KUO ; Lin, Chen-Yuan; Lien, Ming-Yu; ANN-LII CHENG ; CHIH-HUNG HSU Esophagus : official journal of the Japan Esophageal Society00
482022Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular CarcinomaYU-YUN SHAO ; Hsu, Hung-Wei; Wo, Rita Robin; Wang, Han-Yu; ANN-LII CHENG ; CHIH-HUNG HSU Oncology33
492022ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology AnalysisLI-CHUN LU ; Deantonio, Cecilia; Palu, Cintia C; Lee, Yi-Hsuan; Mitchell, Laura S; Cowan, Marianne; Corser, Matthew; Sherry, Lorcan; ANN-LII CHENG ; Quaratino, Sonia; YU-YUN SHAO ; Sainson, Richard C A; CHIH-HUNG HSU Oncology (Switzerland)10
502022Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin gradeKelley R.K.; Miksad R.; Cicin I.; Chen Y.H.; Kl?mpen H.-J.; Kim S.; ZHONG-ZHE LIN ; Youkstetter J.; Hazra S.; Sen S.; ANN-LII CHENG ; El-Khoueiry A.B.; Meyer T.; Abou-Alfa G.K.British Journal of Cancer1714
512021Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II TrialsBANG-BIN CHEN ; ZHONG-ZHE LIN ; YU-YUN SHAO ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH Cancers43
522021Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patientsI-CHUN CHEN ; Hu, Fu-Chang; CHING-HUNG LIN ; Huang, Shu-Min; DWANG-YING CHANG ; ANN-LII CHENG ; YEN-SHEN LU Breast (Edinburgh, Scotland)22
532021Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II StudyKelley, Robin Kate; Sangro, Bruno; Harris, William; Ikeda, Masafumi; Okusaka, Takuji; Kang, Yoon-Koo; Qin, Shukui; Tai, David W-M; Lim, Ho Yeong; Yau, Thomas; Yong, Wei-Peng; ANN-LII CHENG ; Gasbarrini, Antonio; Damian, Silvia; Bruix, Jordi; Borad, Mitesh; Bendell, Johanna; Kim, Tae-You; Standifer, Nathan; He, Philip; Makowsky, Mallory; Negro, Alejandra; Kudo, Masatoshi; Abou-Alfa, Ghassan KJournal of clinical oncology : official journal of the American Society of Clinical Oncology253215
542021Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signalingSUNG-HSIN KUO ; SHIH-HUNG YANG ; Wei, Ming-Feng; Lee, Hsiao-Wei; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH Cancer cell international33
552021Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular CarcinomaBANG-BIN CHEN ; YU-YUN SHAO ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; ANN-LII CHENG ; CHIUN HSU ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH Diagnostics (Basel, Switzerland)77
562021High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaLIN, CHING-HUNG ; RUBY YUN-JU HUANG ; TZU-PIN LU ; KUAN-TING KUO ; Lo, Ko-Yun; Chen, Ching-Hsuan; I-CHUN CHEN ; YEN-SHEN LU ; ERIC YAO-YU CHUANG ; Thiery, Jean Paul; CHIUN-SHENG HUANG ; ANN-LII CHENG NPJ breast cancer44
572021Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohortKUO-HSING CHEN ; LIANG-IN LIN ; CHANG-TSU YUAN ; LI-HUI TSENG ; Chao, Yu-Liang; YI-HSIN LIANG ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH British journal of cancer00
582021Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapyYING-CHUN SHEN ; Yeh C.-P.; YUNG-MING JENG ; CHIUN HSU ; CHIH-HUNG HSU ; ZHONG-ZHE LIN ; YU-YUN SHAO ; LI-CHUN LU ; TSUNG-HAO LIU ; CHIEN-HUNG CHEN ; ANN-LII CHENG Cancers22
592021Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancerKasper S.; Foch C.; Messinger D.; Esser R.; Lamy F.-X.; Rothe V.; Chen W.; ANN-LII CHENG ; Rouyer M.; Brodowicz T.; Zielinski C.European Journal of Cancer78
602021Pharmacodynamic biomarkers predictive of survival benefit with lenvatinib in unresectable hepatocellular carcinoma: From the phase III REFLECT studyFinn R.S.; Kudo M.; ANN-LII CHENG ; Wyrwicz L.; Ngan R.K.C.; Blanc J.-F.; Baron A.D.; Vogel A.; Ikeda M.; Piscaglia F.; Han K.-H.; Qin S.; Minoshima Y.; Kanekiyo M.; Ren M.; Dairiki R.; Tamai T.; Dutcus C.E.; Ikezawa H.; Funahashi Y.; Evans T.R.J.Clinical Cancer Research3229
612021Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trialGalle P.R.; Finn R.S.; Qin S.; Ikeda M.; Zhu A.X.; Kim T.-Y.; Kudo M.; Breder V.; Merle P.; Kaseb A.; Li D.; Mulla S.; Verret W.; Xu D.-Z.; Hernandez S.; Ding B.; Liu J.; Huang C.; Lim H.Y.; ANN-LII CHENG ; Ducreux M.The Lancet Oncology165141
622021An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular CarcinomaYU-YUN SHAO ; ANN-LII CHENG ; CHIH-HUNG HSU Oncologist95
632021Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinomaGreten T.F.; Abou-Alfa G.K.; ANN-LII CHENG ; Duffy A.G.; El-Khoueiry A.B.; Finn R.S.; Galle P.R.; Goyal L.; He A.R.; Kaseb A.O.; Kelley R.K.; Lencioni R.; Lujambio A.; Mabry Hrones D.; Pinato D.J.; Sangro B.; Troisi R.I.; Wilson Woods A.; Yau T.; Zhu A.X.; Melero I.Journal for ImmunoTherapy of Cancer4034
642021Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpressionRyoo B.-Y.; ANN-LII CHENG ; Ren Z.; Kim T.-Y.; Pan H.; Rau K.-M.; Choi H.J.; Park J.-W.; Kim J.H.; Yen C.J.; Lim H.Y.; Zhou D.; Straub J.; Scheele J.; Berghoff K.; Qin S.British Journal of Cancer2117
652021Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trialKudo M.; Lim H.Y.; ANN-LII CHENG ; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y.Liver Cancer3026
662021Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 StudyQin S.; Ren Z.; Feng Y.-H.; Yau T.; Wang B.; Zhao H.; Bai Y.; Gu S.; Li L.; Hernandez S.; Xu D.-Z.; Mulla S.; Wang Y.; Shao H.; ANN-LII CHENG Liver Cancer6249
672021Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYnote-240Ryoo B.-Y.; Merle P.; Kulkarni A.S.; ANN-LII CHENG ; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Daniele B.; Norquist J.M.; Chen E.; Siegel A.B.; Zhu A.X.; Finn R.S.; Kudo M.Cancer1317
682021Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular CarcinomaYU-YUN SHAO ; Sun, Nai-Yun; YUNG-MING JENG ; YAO-MING WU ; CHIUN HSU ; CHIH-HUNG HSU ; Hsu, Hey-Chi; ANN-LII CHENG ; ZHONG-ZHE LIN Cells32
692021Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinomaSHIH-HUNG YANG ; LI-CHUN LU ; HSIANG-FONG KAO ; BANG-BIN CHEN ; TING-CHUN KUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; Bai, Li-Yuan; ANN-LII CHENG ; KUN-HUEI YEH Oncoimmunology34
702021Evolution of systemic treatment for advanced hepatocellular carcinomaWu T.-C.; YING-CHUN SHEN ; ANN-LII CHENG Kaohsiung Journal of Medical Sciences119
712021Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular CarcinomaCHIA-LANG HSU ; DA-LIANG OU ; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; ANN-LII CHENG ; YUNG-MING JENG ; CHIUN HSU Liver Cancer4747
722021APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyLau G.; Yu M.-L.; Wong G.; Thompson A.; Ghazinian H.; Hou J.-L.; Piratvisuth T.; Jia J.-D.; Mizokami M.; Cheng G.; Chen G.-F.; Liu Z.-W.; Baatarkhuu O.; ANN-LII CHENG ; Ng W.L.; Lau P.; Mok T.; Chang J.-M.; Hamid S.; Dokmeci A.K.; Gani R.A.; Payawal D.A.; Chow P.; Park J.-W.; Strasser S.I.; Mohamed R.; Win K.M.; Tawesak T.; Sarin S.K.; Omata M.Hepatology International5241
732021Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomasWEI-LI MA ; KUN-HUEI YEH ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; Wang Y.-T.; Yeh Y.-C.; HSIU-PO WANG ; ANN-LII CHENG ; SUNG-HSIN KUO Journal of the Formosan Medical Association53
742021Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECTOkusaka T.; Ikeda K.; Kudo M.; Finn R.; Qin S.; Han K.-H.; ANN-LII CHENG ; Piscaglia F.; Kobayashi M.; Sung M.; Chen M.; Wyrwicz L.; Yoon J.-H.; Ren Z.; Mody K.; Dutcus C.; Tamai T.; Ren M.; Hayato S.; Kumada H.Journal of Gastroenterology77
752021ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240Vogel, Arndt; Merle, Philippe; Verslype, Chris; Finn, Richard S; Zhu, Andrew X; ANN-LII CHENG ; Chan, Stephen Lam; Yau, Thomas; Ryoo, Baek-Yeol; Knox, Jennifer; Daniele, Bruno; Qin, Shukui; Wei, Ziwen; Miteva, Yanna; Malhotra, Usha; Siegel, Abby B; Kudo, MasatoshiTherapeutic advances in medical oncology86
762021Pursuing efficacious systemic therapy for hepatocellular carcinomaANN-LII CHENG Nature reviews Gastroenterology and Hepatology99
772021Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophagesDA-LIANG OU ; Chen C.-W.; CHIA-LANG HSU ; Chung C.-H.; Feng Z.-R.; Lee B.-S.; ANN-LII CHENG ; Yang M.-H.; CHIUN HSU Journal for ImmunoTherapy of Cancer6844
782020Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular CarcinomaAlsina A.; Kudo M.; Vogel A.; ANN-LII CHENG ; Tak W.Y.; Ryoo B.-Y.; Evans T.R.J.; L?pez L?pez C.; Daniele B.; Misir S.; Ren M.; Izumi N.; Qin S.; Finn R.S.Liver Cancer5448
792020Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaKelley R.K.; Meyer T.; Rimassa L.; Merle P.; Park J.-W.; Yau T.; Chan S.L.; Blanc J.-F.; Tam V.C.; Tran A.; Dadduzio V.; Markby D.W.; Kaldate R.; ANN-LII CHENG ; El-Khoueiry A.B.; Abou-Alfa G.K.Clinical Cancer Research5444
802020IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablationHack S.P.; Spahn J.; Chen M.; ANN-LII CHENG ; Kaseb A.; Kudo M.; Lee H.C.; Yopp A.; Chow P.; Qin S.Future Oncology130105
812020Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. ReplyFinn R.S.; ANN-LII CHENG The New England journal of medicine28
822020Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular CarcinomaKelley R.K.; Mollon P.; Blanc J.-F.; Daniele B.; Yau T.; ANN-LII CHENG ; Valcheva V.; Marteau F.; Guerra I.; Abou-Alfa G.K.Advances in Therapy3128
832020Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinomaSangro B.; Melero I.; Wadhawan S.; Finn R.S.; Abou-Alfa G.K.; ANN-LII CHENG ; Yau T.; Furuse J.; Park J.-W.; Boyd Z.; Tang H.T.; Shen Y.; Tschaika M.; Neely J.; El-Khoueiry A.Journal of Hepatology232207
842020Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western PopulationsChen C.-H.; YEN-SHEN LU ; ANN-LII CHENG ; CHIUN-SHENG HUANG ; WEN-HUNG KUO ; Wang M.-Y.; Chao M.; I-CHUN CHEN ; Kuo C.-W.; TZU-PIN LU ; CHING-HUNG LIN Oncologist3232
852020Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survivalWEI-WU CHEN ; I-SHIOW JAN ; DWANG-YING CHANG ; CHING-HUNG LIN ; I-CHUN CHEN ; Chen H.-M.; ANN-LII CHENG ; YEN-SHEN LU Journal of Neuro-Oncology1713
862020Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patientsSHIH-HUNG YANG ; JHE-CYUAN GUO ; CHIUN HSU ; SUNG-HSIN KUO ; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH Journal of the Formosan Medical Association33
872020A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumorsJIH-HSIANG LEE ; WEI-WU CHEN ; CHIH-HUNG HSU ; Yen Y.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; CHIA-CHI LIN Investigational New Drugs3936
882020Atezolizumab plus bevacizumab in unresectable hepatocellular carcinomaFinn R.S.; Qin S.; Ikeda M.; Galle P.R.; Ducreux M.; Kim T.-Y.; Kudo M.; Breder V.; Merle P.; Kaseb A.O.; Li D.; Verret W.; Xu D.-Z.; Hernandez S.; Liu J.; Huang C.; Mulla S.; Wang Y.; Lim H.Y.; Zhu A.X.; ANN-LII CHENG ; IMbrave150 InvestigatorsNew England Journal of Medicine36923126
892020Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinomaANN-LII CHENG ; CHIUN HSU ; Chan S.L.; Choo S.-P.; Kudo M.Journal of Hepatology306267
902020Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trialKelley R.K.; Ryoo B.-Y.; Merle P.; Park J.-W.; Bolondi L.; Chan S.L.; Lim H.Y.; Baron A.D.; Parnis F.; Knox J.; Cattan S.; Yau T.; Lougheed J.C.; Milwee S.; El-Khoueiry A.B.; ANN-LII CHENG ; Meyer T.; Abou-Alfa G.K.ESMO open4746
912020Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study designKelley R.K.; W Oliver J.; Hazra S.; Benzaghou F.; Yau T.; ANN-LII CHENG ; Rimassa L.Future Oncology5149
922020A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissueTsai H.-J.; Tai J.J.; Chen L.-T.; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; Wang T.-E.; HSIU-PO WANG ; Yu F.-J.; JYH-MING LIOU ; Hsiao C.-F.; TSU-YAO CHENG ; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; CHIA-TUNG SHUN ; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; SUNG-HSIN KUO ; ANN-LII CHENG Haematologica55
932020Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumoursde Bono J.; CHIA-CHI LIN ; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; JIH-HSIANG LEE ; CHIH-HUNG HSU ; CHIH-HSIN YANG ; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; ANN-LII CHENG British Journal of Cancer2017
942020A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese womenLien, Guang-Wen; WU-SHIUN HSIEH ; WEN-HUNG KUO ; CHING-HUA KUO ; Huang, Ching-Chun; YUE-LIANG GUO; DWANG-YING CHANG ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN ; PAU-CHUNG CHEN Environment International4935
952020A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib MonotherapyZHONG-ZHE LIN ; BANG-BIN CHEN ; Hung, Yi-Ping; HUANG, PO-HSIANG ; Ying-Chun Shen ; YU-YUN SHAO ; CHIH-HUNG HSU ; ANN-LII CHENG ; Lee, Rheun-Chuan; Chao, Yee; CHIUN HSU Oncologist1210
962020Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYnote-240: A Randomized, Double-Blind, Phase III TrialFinn R.S.; Ryoo B.-Y.; Merle P.; Kudo M.; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Knox J.; Daniele B.; Ebbinghaus S.W.; Chen E.; Siegel A.B.; Zhu A.X.; ANN-LII CHENG ; KEYnote-240 investigatorsJournal of clinical oncology : official journal of the American Society of Clinical Oncology11881028
972020Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSOChen L.-T.; Martinelli E.; ANN-LII CHENG ; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; CHIUN HSU ; YING-CHUN SHEN ; Tabernero J.; Yen Y.; CHIH-HUNG HSU ; Yoshino T.; Douillard J.-Y.Annals of Oncology128112
982020Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infectionTsou H.-H.; HUNG-CHIH YANG ; Hsiao C.-F; Hsiung C.A; Liu T.-W; Chuang M.-H; Wu H.-Y; Hsu Y.-T; Tsui C.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology GroupJournal of the Formosan Medical Association88
992020Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinomaYing-Chun Shen ; CHIA-LANG HSU ; YUNG-MING JENG ; MING-CHIH HO ; CHENG-MAW HO ; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; REY-HENG HU ; ANN-LII CHENG Journal of Hepatology3535
1002020Milestones in the pathogenesis and management of primary liver cancerNault J.-C.; ANN-LII CHENG ; Sangro B.; Llovet J.M.Journal of Hepatology3935
1012020A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus StatementsKudo M.; Han K.-H.; Ye S.-L.; Zhou J.; Huang Y.-H.; Lin S.-M.; Wang C.-K.; Ikeda M.; Chan S.L.; Choo S.P.; Miyayama S.; ANN-LII CHENG Liver Cancer150146
1022020Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancerWEN-CHI YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; ZHONG-ZHE LIN ; Lu S.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; SUNG-HSIN KUO Clinical and Translational Radiation Oncology118
1032019Considerations of heterogeneity in clinical trials for hepatocellular carcinomaTSUNG-HAO LIU ; YU-YUN SHAO ; LI-CHUN LU ; Ying-Chun Shen ; CHIUN HSU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; ANN-LII CHENG Expert Review of Gastroenterology and Hepatology57
1042019The APPLE association president's messageANN-LII CHENG Liver Cancer00
1052019Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular CarcinomaDA-LIANG OU ; Lin, Yu-Yang; CHIA-LANG HSU ; Lin, Yin-Yao; Chen, Chia-Wei; Yu, Jhang-Sian; SHI-CHUEN MIAW ; PING-NING HSU ; ANN-LII CHENG ; CHIUN HSU Liver cancer2421
1062019The APPLE Association President's MessageANN-LII CHENG Liver Cancer00
1072019Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib TreatmentLI-CHUN LU ; Lee, Yi Hsuan; Chang, Chun Jung; CHIA-TUNG SHUN ; Fang, Chih Yeu; YU-YUN SHAO ; TSUNG-HAO LIU ; ANN-LII CHENG ; CHIH-HUNG HSU Liver Cancer4541
1082019Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphomaSUNG-HSIN KUO ; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; PING-NING HSU ; Chen L.-T.; ANN-LII CHENG Cancers2122
1092019Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular CarcinomaLI-CHUN LU ; CHIUN HSU ; YU-YUN SHAO ; Chao Y.; Yen C.-J.; I-LUN SHIH ; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen ; JHE-CYUAN GUO ; TSUNG-HAO LIU ; CHIH-HUNG HSU ; ANN-LII CHENG Liver Cancer4644
1102019Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal CancerYU-HSUAN CHEN ; CHUN-WEI WANG ; Wei M.-F.; Tzeng Y.-S.; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO Cancers99
1112019Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (British Journal of Cancer, (2019), 121, 3, (218-221), 10.1038/s41416-019-0506-6)Evans T.R.J.; Kudo M.; Finn R.S.; Han K.-H.; ANN-LII CHENG ; Ikeda M.; Kraljevic S.; Ren M.; Dutcus C.E.; Piscaglia F.; Sung M.W.British Journal of Cancer22
1122019Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectivenessCHE-YU HSU ; CHUN-WEI WANG ; ANN-LII CHENG ; SUNG-HSIN KUO World Journal of Gastrointestinal Oncology75
1132019Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US PopulationCHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; CHIUN-SHENG HUANG ; ANN-LII CHENG ; YEN-SHEN LU ; Asian Breast Cancer Cooperative GroupJournal of the National Cancer Institute8273
1142019Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinomaYU-YUN SHAO ; TSUNG-HAO LIU ; CHIUN HSU ; LI-CHUN LU ; YING-CHUN SHEN ; ZHONG-ZHE LIN ; ANN-LII CHENG ; CHIH-HUNG HSU Liver International5858
1152019Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid TumorsDoi T.; CHIH-HSIN YANG ; Shitara K.; Naito Y.; ANN-LII CHENG ; Sarashina A.; Pronk L.C.; Takeuchi Y.; CHIA-CHI LIN Targeted Oncology2214
1162019Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular CarcinomaYU-YUN SHAO ; Yong-Shi Li; Hung-Wei Hsu; Hang Lin; Han-Yu Wang; Rita Robin Wo; ANN-LII CHENG ; CHIH-HUNG HSU Cancers1414
1172019CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal CancerKUO-HSING CHEN ; LIANG-IN LIN ; LI-HUI TSENG ; Lin, Yu-Lin; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH Oncology64
1182019Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinomaTa-Chen Huang ; CHIA-CHI LIN ; Wu Y.-C.; CHIA-HSIEN CHENG ; JANG-MING LEE ; HSIU-PO WANG ; PEI-MING HUANG ; Feng-Ming Hsu ; KUN-HUEI YEH ; ANN-LII CHENG ; KAI-YUAN TZEN ; CHIH-HUNG HSU Journal of the Formosan Medical Association86
1192019Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinomaZHONG-ZHE LIN ; CHIUN HSU ; YUNG-MING JENG ; Hu F.-C.; Pan H.-W.; YAO-MING WU ; Hsu H.-C.; ANN-LII CHENG Liver International1818
1202019The APPLE association president's messageANN-LII CHENG Liver Cancer00
1212019Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancerPrice T.; Shen L.; Ma B.; Esser R.; Chen W.; Gibbs P.; Lim R.; ANN-LII CHENG Asia-Pacific Journal of Clinical Oncology44
1222019Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaEvans T.R.J.; Kudo M.; Finn R.S.; Han K.-H.; ANN-LII CHENG ; Ikeda M.; Kraljevic S.; Ren M.; Dutcus C.E.; Piscaglia F.; Sung M.W.British Journal of Cancer1919
1232018The APPLE Association President's MessageANN-LII CHENG Liver Cancer00
1242018A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinomaSHIH-HUNG YANG ; YU-YUN SHAO ; CHIA-CHI LIN ; SUNG-HSIN KUO ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research32
1252018Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of TaiwanWang, CK; MING-CHIH HO ; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN ; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; PO-HUANG LEE ; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Lin S.-M.; GUAN-TARN HUANG ; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG ; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; ANN-LII CHENG ; CHIUN HSU ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI ; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting groupJournal of the Formosan Medical Association = Taiwan yi zhi9087
1262018The APPLE association president's messageANN-LII CHENG Liver Cancer00
1272018Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancerBANG-BIN CHEN ; YEN-SHEN LU ; CHIH-WEI YU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH European Radiology99
1282018Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYnote-224): a non-randomised, open-label phase 2 trialZhu A.X.; Finn R.S.; Edeline J.; Cattan S.; Ogasawara S.; Palmer D.; Verslype C.; Zagonel V.; Fartoux L.; Vogel A.; Sarker D.; Verset G.; Chan S.L.; Knox J.; Daniele B.; Webber A.L.; Ebbinghaus S.W.; Ma J.; Siegel A.B.; ANN-LII CHENG ; Kudo M.; Alistar A.; Asselah J.; Blanc J.-F.; Borbath I.; Cannon T.; Chung K.; Cohn A.; Cosgrove D.P.; Damjanov N.; Gupta M.; Karino Y.; Karwal M.; Kaubisch A.; Kelley R.; Van Laethem J.-L.; Larson T.; Lee J.; Li D.; Manhas A.; Manji G.A.; Numata K.; Parsons B.; Paulson A.S.; Pinto C.; Ramirez R.; Ratnam S.; Rizell M.; Rosmorduc O.; Sada Y.; Sasaki Y.; Stal P.I.; Strasser S.; Trojan J.; Vaccaro G.; Van Vlierberghe H.; Weiss A.; Weiss K.-H.; Yamashita T.; KEYnote-224 investigatorsThe Lancet Oncology17441573
1292018Adiposity, inflammation, and breast cancer pathogenesis in Asian WomenIyengar N.M.; I-CHUN CHEN ; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; YEN-SHEN LU ; Hsueh T.-H.; ANN-LII CHENG ; Hudis C.A.; CHING-HUNG LIN ; Dannenberg A.J.Cancer Prevention Research3430
1302018The HER2 inhibitor lapatinib potentiates doxorubicininduced cardiotoxicity through iNOS signalingWAN-TSENG HSU ; Huang C.-Y.; Yen C.Y.T.; ANN-LII CHENG ; Hsieh P.C.H.Theranostics3833
1312018Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinomaChang C.-J.; YAO-HSU YANG ; Chiu C.-J.; LI-CHUN LU ; Liao C.-C.; Liang C.-W.; CHIH-HUNG HSU ; ANN-LII CHENG International Journal of Cancer4437
1322018Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trialKudo M.; Finn R.S.; Qin S.; Han K.-H.; Ikeda K.; Piscaglia F.; Baron A.; Park J.-W.; Han G.; Jassem J.; Blanc J.F.; Vogel A.; Komov D.; Evans T.R.J.; Lopez C.; Dutcus C.; Guo M.; Saito K.; Kraljevic S.; Tamai T.; Ren M.; ANN-LII CHENG The Lancet34423008
1332018A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerWEI-WU CHEN ; Yeh D.-C.; Chao T.-Y.; CHING-HUNG LIN ; Chow L.W.-C.; DWANG-YING CHANG ; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU ; Taiwan Breast Cancer ConsortiumJapanese Journal of Clinical Oncology43
1342018Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infectionHUNG-CHIH YANG ; Tsou H.-H; Pei S.-N; Chang C.-S; Chen J.-H; MING YAO ; Lin S.-J; Lin J; Yuan Q; Xia N; Liu T.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology GroupJournal of Hepatology6958
1352018Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 studyKudo M.; ANN-LII CHENG ; Park J.-W.; Park J.H.; PO-CHIN LIANG ; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y.The Lancet Gastroenterology and Hepatology126114
1362018Recent developments of c-Met as a therapeutic target in hepatocellular carcinomaBouattour M.; Raymond E.; Qin S.; ANN-LII CHENG ; Stammberger U.; Locatelli G.; Faivre S.Hepatology183172
1372018Reply to: “Predictors of sorafenib benefit in patients with hepatocellular carcinoma”Bruix J.; ANN-LII CHENG ; Llovet J.Journal of Hepatology10
1382018Cabozantinib in patients with advanced and progressing hepatocellular carcinomaAbou-Alfa G.K.; Meyer T.; ANN-LII CHENG ; El-Khoueiry A.B.; Rimassa L.; Ryoo B.-Y.; Cicin I.; Merle P.; Chen Y.; Park J.-W.; Blanc J.-F.; Bolondi L.; Kl?mpen H.-J.; Chan S.L.; Zagonel V.; Pressiani T.; Ryu M.-H.; Venook A.P.; Hessel C.; Borgman-Hagey A.E.; Schwab G.; Kelley R.K.New England Journal of Medicine15621405
1392018Effect of glucocorticoid use on survival in patients with stage I–III breast cancerCHING-HUNG LIN ; Chuang P.-Y.; You S.-L.; CHUN-JU CHIANG ; CHIUN-SHENG HUANG ; Wang M.-Y.; Chao M.; YEN-SHEN LU ; ANN-LII CHENG ; Tang C.-H.Breast Cancer Research and Treatment88
1402018Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of ImmunotherapyLin Y.-Y.; CHING-TING TAN ; Chen C.-W.; DA-LIANG OU ; ANN-LII CHENG ; CHIUN HSU Seminars in Liver Disease6253
1412018Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in miceCHIAO-LING TSAI ; Liu W.-L.; Feng-Ming Hsu ; Yang P.-S.; RUOH-FANG YEN ; KAI-YUAN TZEN ; ANN-LII CHENG ; PEI-JER CHEN ; CHIA-HSIEN CHENG Hepatology2826
1422018Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cellsWu C.-H.; Yang Y.-H.; MEI-RU CHEN ; CHING-HWA TSAI ; ANN-LII CHENG ; SHIN-LIAN DOONG PLoS ONE32
1432018Corrigendum to “Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies” [J hepatol 67 (2017) 999–1008](S0168827817321347)(10.1016/j.jhep.2017.06.026))Bruix J.; ANN-LII CHENG ; Meinhardt G.; Nakajima K.; De Sanctis Y.; Llovet J.Journal of Hepatology64
1442018Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancerWAN-YU CHEN ; CHEN-TU WU ; CHUN-WEI WANG ; KENG-HSUEH LAN ; HSIANG-KUANG LIANG ; Huang B.-S.; YIH-LEONG CHANG ; SUNG-HSIN KUO ; ANN-LII CHENG Radiation Oncology2525
1452018A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular CarcinomaYen C.-J.; Kim T.-Y.; Feng Y.-H.; Chao Y.; Lin D.-Y.; Ryoo B.-Y.; Huang D.C.-L.; Schnell D.; Hocke J.; Loemb? A.-B.; ANN-LII CHENG Liver Cancer1922
1462018The APPLE Association President's MessageANN-LII CHENG Liver Cancer00
1472017The APPLE Association President's MessageANN-LII CHENG Liver Cancer00
1482017Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cellsYU-YUN SHAO ; MIN-SHU HSIEH ; Wang, Han Yu; Li, Yong Shi; Lin, Hang; Hsu, Hung Wei; Huang, Chung Yi; CHIH-HUNG HSU ; ANN-LII CHENG Oncotarget129
1492017Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacyYU-YUN SHAO ; BANG-BIN CHEN ; DA-LIANG OU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; Wang, M. J.; ANN-LII CHENG ; CHIUN HSU Alimentary Pharmacology and Therapeutics108
1502017Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database studyYI-HSIN LIANG ; YU-YUN SHAO ; Chen, Ho Min; ANN-LII CHENG ; Lai, Mei Shu; KUN-HUEI YEH Anticancer Research1011
1512017Tumor compactness improves the preoperative volumetrybased prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapyCHE-YU HSU ; CHUN-WEI WANG ; Kuo C.-C.; YU-HSUAN CHEN ; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO Oncotarget1212
1522017Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric CancerTsai K.-F.; JYH-MING LIOU ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; SUNG-HSIN KUO ; I-RUE LAI ; KUN-HUEI YEH ; MING-TSAN LIN ; HSIU-PO WANG ; ANN-LII CHENG ; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU PLoS ONE2925
1532017Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to TamoxifenI-CHUN CHEN ; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; CHING-HUNG LIN ; Wei-Wu Chen T.; ANN-LII CHENG ; YEN-SHEN LU Scientific Reports2320
1542017First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphomaSUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; Wei M.-F.; JYH-MING LIOU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG Scientific Reports1718
1552017The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)SUNG-HSIN KUO ; Tsai H.-J.; CHUNG-WU LIN ; KUN-HUEI YEH ; Lee H.-W.; Wei M.-F.; CHIA-TUNG SHUN ; MING-SHIANG WU ; PING-NING HSU ; Chen L.-T.; ANN-LII CHENG Journal of Pathology1212
1562017Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphomaWEN-CHI YANG ; CHUN-WEI WANG ; RUEY-LONG HONG ; CHIAO-LING TSAI ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; ANN-LII CHENG ; SUNG-HSIN KUO Journal of Radiation Research99
1572017Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCLSUNG-HSIN KUO ; Chen L.-T.; CHUNG-WU LIN ; KUN-HUEI YEH ; CHIA-TUNG SHUN ; Tzeng Y.-S.; JYH-MING LIOU ; MING-SHIANG WU ; PING-NING HSU ; ANN-LII CHENG Blood2016
1582017Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialBruix J.; Qin S.; Merle P.; Granito A.; Huang Y.-H.; Bodoky G.; Pracht M.; Yokosuka O.; Rosmorduc O.; Breder V.; Gerolami R.; Masi G.; Ross P.J.; Song T.; Bronowicki J.-P.; Ollivier-Hourmand I.; Kudo M.; ANN-LII CHENG ; Llovet J.M.; Finn R.S.; LeBerre M.-A.; Baumhauer A.; Meinhardt G.; Han G.The Lancet26542396
1592017A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvementYUN CHIANG ; CHIA-HSIEN CHENG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Chia-Chi Lin ; CHIH-HUNG HSU ; ANN-LII CHENG ; YEONG-SHIAU PU Journal of the Formosan Medical Association76
1602017mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenibMeyer T.; Palmer D.H.; ANN-LII CHENG ; Hocke J.; Loemb? A.-B.; Yen C.-J.Liver International5949
1612017Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancerOkusaka T.; Miyakawa H.; Fujii H.; Nakamori S.; Satoh T.; Hamamoto Y.; Ito T.; Maguchi H.; Matsumoto S.; Ueno H.; Ioka T.; Boku N.; Egawa S.; Hatori T.; Furuse J.; Mizumoto K.; Ohkawa S.; Yamaguchi T.; Yamao K.; Funakoshi A.; Chen J.S.; ANN-LII CHENG ; Sato A.; Ohashi Y.; Tanaka M.; on behalf of the GEST groupJournal of Cancer Research and Clinical Oncology2518
1622017National policies fostering hospice care increased hospice utilization and reduced the invasiveness of end-of-life care for cancer patientsYU-YUN SHAO ; Hsiue E.H.-C.; CHIH-HUNG HSU ; CHIEN-AN YAO ; Chen H.-M.; Lai M.-S.; ANN-LII CHENG Oncologist2117
1632017Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology01
1642017Corrigendum to “Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells” [Neoplasia (United States) 14 (2012) 463–475](S1476558612801023)(10.1596/neo.12300)Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Chuang S.-H.; Chen K.-F.; ANN-LII CHENG ; CHING-CHOW CHEN Neoplasia (United States)00
1652017Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomasWEI-LI MA ; MING YAO ; SHU-LANG LIAO ; JIH-LUH TANG ; Wang Y.-C.; SUNG-HSIN KUO ; ANN-LII CHENG Oncotarget64
1662017Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population studyLI-CHUN LU ; PEI-JER CHEN ; Yeh Y.-C.; CHIH-HUNG HSU ; Chen H.-M.; Lai M.-S.; YU-YUN SHAO ; ANN-LII CHENG Anticancer Research1516
1672017Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST studyHagiwara Y.; Ohashi Y.; Okusaka T.; Ueno H.; Ioka T.; Boku N.; Egawa S.; Hatori T.; Furuse J.; Mizumoto K.; Ohkawa S.; Yamaguchi T.; Yamao K.; Funakoshi A.; ANN-LII CHENG ; Kihara K.; Sato A.; Tanaka M.ESMO Open1040
1682017High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinomaYU-YUN SHAO ; Lin H.; Li Y.-S.; Lee Y.-H.; Chen H.-M.; ANN-LII CHENG ; CHIH-HUNG HSU Japanese Journal of Clinical Oncology3531
1692017Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047))Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology11
1702017Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyANN-LII CHENG ; Cornelio G.; Shen L.; Price T.; Yang T.-S.; Chung I.J.; Dai G.-H.; Lin J.-K.; Sharma A.; KUN-HUEI YEH ; Ma B.; Zaatar A.; Guan Z.; Masood N.; Srimuninnimit V.; Yau T.; Gibbs P.; Wang X.; Doval D.C.; Oh S.-T.; Shim B.Y.; Gorospe C.; Wang H.-M.; Sirachainan E.; Hill A.; Suh K.W.; Beier F.; Chatterjee S.; Lim R.Clinical Colorectal Cancer2119
1712017Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancerYI-HSIN LIANG ; Wei, C. H.; Hsu, W. H.; YU-YUN SHAO ; Lin, Y. C.; Chou, P. C.; ANN-LII CHENG ; KUN-HUEI YEH Support Care Cancer1010
1722017Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)Abou-Alfa G.K.; Yen C.-J.; CHIH-HUNG HSU ; O��Donoghue J.; Beylergil V.; Ruan S.; Pandit-Taskar N.; Gansukh B.; Lyashchenko S.K.; Ma J.; Wan P.; YU-YUN SHAO ; ZHONG-ZHE LIN ; Frenette C.; O��Neil B.; Schwartz L.; Smith-Jones P.M.; Ohtomo T.; Tanaka T.; Morikawa H.; Maki Y.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Di Laurenzio L.; Lee R.; Larson S.M.; ANN-LII CHENG ; Carrasquilo J.A.Cancer Chemotherapy and Pharmacology2019
1732017Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapySHIH-HUNG YANG ; JEN-CHIEH LEE ; JHE-CYUAN GUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; TING-CHUN KUO ; ANN-LII CHENG ; KUN-HUEI YEH PLoS ONE63
1742017Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinomaBANG-BIN CHEN ; CHAO-YU HSU ; CHIH-WEI YU ; PO-CHIN LIANG ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; TIFFANY TING-FANG SHIH European Radiology1517
1752017Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateOmata M.; ANN-LII CHENG ; Kokudo N.; Kudo M.; Lee J.M.; Jia J.; Tateishi R.; Han K.-H.; Chawla Y.K.; Shiina S.; Jafri W.; Payawal D.A.; Ohki T.; Ogasawara S.; PEI-JER CHEN ; Lesmana C.R.A.; Lesmana L.A.; Gani R.A.; Obi S.; Dokmeci A.K.; Sarin S.K.Hepatology International14901303
1762017Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studiesBruix J.; ANN-LII CHENG ; Meinhardt G.; Nakajima K.; De Sanctis Y.; Llovet J.Journal of Hepatology415402
1772016Relapse pattern and treatment outcome of curative radiotherapy for primary cutaneous CD30+ anaplastic large-cell lymphoma: A retrospective cohort studyHuang B.-S.; WAN-YU CHEN ; CHUN-WEI WANG ; ANN-LII CHENG ; Hong J.-H.; SUNG-HSIN KUO Acta Dermato-Venereologica33
1782016Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosisI-CHUN CHEN ; CHING-HUNG LIN ; I-SHIOW JAN ; ANN-LII CHENG ; YEN-SHEN LU Journal of the Formosan Medical Association1811
1792016Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinomaLin H.-H.; Feng W.-C.; LI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; ANN-LII CHENG Cancer letters3739
1802016Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinomaANN-LII CHENG ; Thongprasert S.; Lim H.Y.; Sukeepaisarnjaroen W.; Yang T.-S.; Wu C.-C.; Chao Y.; Chan S.L.; Kudo M.; Ikeda M.; Kang Y.-K.; Pan H.; Numata K.; Han G.; Balsara B.; Zhang Y.; Rodriguez A.-M.; Zhang Y.; Wang Y.; Poon R.T.P.Hepatology7268
1812016Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerSHIH-HUNG YANG ; TING-CHUN KUO ; Wu H.; JHE-CYUAN GUO ; CHIUN HSU ; CHIH-HUNG HSU ; YU-WEN TIEN ; KUN-HUEI YEH ; ANN-LII CHENG ; SUNG-HSIN KUO World Journal of Gastroenterology2425
1822016Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancerSHIH-HUNG YANG ; JHE-CYUAN GUO ; KUN-HUEI YEH ; YU-WEN TIEN ; ANN-LII CHENG ; SUNG-HSIN KUO Journal of Gastroenterology and Hepatology (Australia)77
1832016Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapyBANG-BIN CHEN ; CHAO-YU HSU ; CHIH-WEI YU ; PO-CHIN LIANG ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; TIFFANY TING-FANG SHIH Radiology2725
1842016Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionCHIUN HSU ; LIANG-IN LIN ; Cheng, Yu-Che; Feng, Zi-Rui; YU-YUN SHAO ; ANN-LII CHENG ; DA-LIANG OU Clinical Cancer Research4341
1852016Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast CancerI-CHUN CHEN ; Chang Y.-C.; YEN-SHEN LU ; KUEI-PIN CHUNG ; CHIUN-SHENG HUANG ; TZU-PIN LU ; WEN-HUNG KUO ; Wang M.-Y.; KUAN-TING KUO ; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; CHING-HUNG LIN ; ANN-LII CHENG Scientific Reports1817
1862016Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinomaYU-YUN SHAO ; TSUNG-HAO LIU ; Lee, Ying-Hui; CHIH-HUNG HSU ; ANN-LII CHENG J. Gastroenterol. Hepatol.2624
1872016Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily PracticeYI-HSIN LIANG ; YU-YUN SHAO ; BIN-CHI LIAO ; Lee, Ho-Sheng; CHIH-HSIN YANG ; Chen, Ho-Min; CHUN-JU CHIANG ; ANN-LII CHENG ; Lai, Mei-ShuJournal of Cancer87
1882016Tumor heterogeneity in hepatocellular carcinoma: Facing the challengesLI-CHUN LU ; CHIH-HUNG HSU ; CHIUN HSU ; ANN-LII CHENG Liver Cancer9598
1892016A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancerBANG-BIN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wu P.-F.; CHAO-YU HSU ; CHIH-WEI YU ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH BMC Cancer2017
1902016A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T KungLiu K.-J.; Chao T.-Y.; Chang J.-Y.; ANN-LII CHENG ; Ch'Ang H.-J.; Kao W.-Y.; Wu Y.-C.; Yu W.-L.; Chung T.-R.; Whang-Peng J.Journal of Biomedical Science1916
1912016Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cellsCho C.-Y.; Huang J.-S.; Shiah S.-G.; Chung S.-Y.; Lay J.-D.; Yang Y.-Y.; Lai G.-M.; ANN-LII CHENG ; Chen L.-T.; Chuang S.-E.RNA3332
1922016BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancerKUO-HSING CHEN ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG Medical Oncology1918
1932016Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without RadiotherapySHIH-FAN LAI ; YU-HSUAN CHEN ; WEN-HUNG KUO ; HUANG-CHUN LIEN ; Wang M.-Y.; YEN-SHEN LU ; Chiao Lo ; SUNG-HSIN KUO ; ANN-LII CHENG ; CHIUN-SHENG HUANG Annals of Surgical Oncology3228
1942016Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort studyKUO-HSING CHEN ; YU-YUN SHAO ; Chen H.-M.; Lin Y.-L.; ZHONG-ZHE LIN ; Lai M.-S.; ANN-LII CHENG ; KUN-HUEI YEH BMC Cancer4139
1952015Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014)CHIUN HSU ; BANG-BIN CHEN ; CHIEN-HUNG CHEN ; MING-CHIH HO ; CHIA-HSIEN CHENG ; Kokudo N.; Murakami T.; Yeo W.; Seong J.; Jia J.-D.; Han K.-H.; ANN-LII CHENG Liver Cancer1722
1962015Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cellsYU-CHIEH TSAI ; Ho P.-Y.; KAI-YUAN TZEN ; Tuan T.-F.; Liu W.-L.; ANN-LII CHENG ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG Molecular Cancer Therapeutics2526
1972015High serum transforming growth factor-β1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenibLin T.-H.; YU-YUN SHAO ; Chan S.-Y.; Huang C.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG Clinical Cancer Research7878
1982015Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patientsChang T.C.; Shiah H.S.; CHIH-HSIN YANG ; KUN-HUEI YEH ; ANN-LII CHENG ; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T.Cancer Chemotherapy and Pharmacology8774
1992015Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpartChang C.; CHING-HUNG LIN ; ANN-LII CHENG ; Medeiros L.J.; Chang K.-C.Histopathology2323
2002015Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinomaBIN-CHI LIAO ; YU-YUN SHAO ; Chen H.-M.; Shau W.-Y.; ZHONG-ZHE LIN ; Kuo R.N.; Lai C.-L.; KUO-HSING CHEN ; ANN-LII CHENG ; CHIH-HSIN YANG ; Lai M.-S.Clinical Lung Cancer118
2012015High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian countryCHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG PLoS ONE106
2022015AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-B activationTsai H.-J.; Shih N.-Y.; SUNG-HSIN KUO ; ANN-LII CHENG ; Lin H.-Y.; Chen T.-Y.; Chang K.-C.; Lin S.-F.; Chang J.S.; Chen L.-T.Leukemia and Lymphoma71
2032015Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinomaDA-LIANG OU ; Shyue S.-K.; LIANG-IN LIN ; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; CHIUN HSU ; ANN-LII CHENG Oncotarget129
2042015TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 AssaysCHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG Scientific Reports1011
2052015Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinomaCHIAO-LING TSAI ; Feng-Ming Hsu ; KAI-YUAN TZEN ; Liu W.-L.; ANN-LII CHENG ; CHIA-HSIEN CHENG Journal of Gastroenterology and Hepatology (Australia)2928
2062015Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancerYU-HSUAN CHEN ; Wei M.-F.; CHUN-WEI WANG ; Lee H.-W.; Pan S.-L.; Gao M.; SUNG-HSIN KUO ; ANN-LII CHENG ; Teng C.-M.Cancer letters4239
2072015The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseasesYUN CHIANG ; CHIH-HSIN YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO PLoS ONE99
2082015Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphomaSUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; MING-SHIANG WU ; JYH-MING LIOU ; Tsai H.-J.; Tzeng Y.-S.; ANN-LII CHENG American Journal of Surgical Pathology1616
2092015Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutationsYI-HSIN LIANG ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LI-HUI TSENG ; LIANG-IN LIN ; YIH-LEONG CHANG ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research44
2102015Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinomaJHE-CYUAN GUO ; Ta-Chen Huang ; CHIA-CHI LIN ; MIN-SHU HSIEH ; Chang C.-H.; PEI-MING HUANG ; JANG-MING LEE ; Feng-Ming Hsu ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG ; CHIH-HUNG HSU Journal of Thoracic Oncology1516
2112015Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapyYEN-SHEN LU ; WEI-WU CHEN ; CHING-HUNG LIN ; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; BANG-BIN CHEN ; Chao T.-C.; Huang S.-M.; CHIUN-SHENG HUANG ; TIFFANY TING-FANG SHIH ; ANN-LII CHENG ; Taiwan Breast Cancer ConsortiumClinical Cancer Research6559
2122015The prognostic impact of type 2 diabetes mellitus on early cervical cancer in AsiaHUNG-YANG KUO ; ZHONG-ZHE LIN ; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; YU-YUN SHAO ; CHIUN HSU ; WEN-FANG CHENG ; ANN-LII CHENG ; CHIH-HSIN YANG ; Lai M.-S.Oncologist1010
2132015Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?YU-YUN SHAO ; CHIH-HUNG HSU ; ANN-LII CHENG World Journal of Gastroenterology3638
2142015Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in TaiwanYU-YUN SHAO ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; ZHONG-ZHE LIN ; ANN-LII CHENG ; Lai M.-S.Clinical Colorectal Cancer3532
2152015Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized studyANN-LII CHENG ; Kang Y.-K.; He A.R.; Lim H.Y.; Ryoo B.-Y.; Hung C.-H.; Sheen I.-S.; Izumi N.; Austin T.; Wang Q.; Greenberg J.; Shiratori S.; Beckman R.A.; Kudo M.Journal of Hepatology3942
2162015The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancerWang Y.-J.; CHAO-YUAN HUANG ; Hou W.-H.; CHIA-CHUN WANG ; KENG-HSUEH LAN ; CHUNG-HSIN CHEN ; HONG-JENG YU ; Lai M.-K.; ANN-LII CHENG ; SHIH-PING LIU ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG World Journal of Surgical Oncology54
2172015Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trialsYU-YUN SHAO ; Shau, W.-Y.; Chan, S.-Y.; LI-CHUN LU ; CHIH-HUNG HSU ; ANN-LII CHENG Oncology (Switzerland)3029
2182015A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosisWu P.-F.; CHING-HUNG LIN ; CHING-HUA KUO ; WEI-WU CHEN ; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU BMC Cancer4836
2192015Young patients with colorectal cancer have increased risk of second primary cancersYI-HSIN LIANG ; YU-YUN SHAO ; Chen H.-M.; Lai C.-L.; ZHONG-ZHE LIN ; Kuo R.N.; ANN-LII CHENG ; KUN-HUEI YEH ; Lai M.-S.Japanese Journal of Clinical Oncology1211
2202014Preoperative prognostic neurologic index for glioblastoma patients receiving tumor resectionHSIANG-KUANG LIANG ; CHUN-WEI WANG ; Tseng, Han-Min; CHAO YUAN HUANG ; KENG-HSUEH LAN ; YU-HSUAN CHEN ; You, San-Lin; CHIA-HSIEN CHENG ; ANN-LII CHENG ; SUNG-HSIN KUO Annals of surgical oncology87
2212014Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruptionZHONG-ZHE LIN ; Chou, Chia-Hung; ANN-LII CHENG ; Liu, Wei-Lin; CHIA-HSIEN CHENG Int. J. Cancer1715
2222014Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinomaLiu W.-L.; Gao M.; KAI-YUAN TZEN ; CHIAO-LING TSAI ; Feng-Ming Hsu ; ANN-LII CHENG ; CHIA-HSIEN CHENG Oncotarget3839
2232014β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinomaLI-CHUN LU ; YU-YUN SHAO ; Lee Y.-H.; MIN-SHU HSIEH ; Hsiao C.-H.; Lin H.-H.; HSIANG-FONG KAO ; Ma Y.-Y.; Yen F.-C.; ANN-LII CHENG ; CHIH-HUNG HSU Oncology (Switzerland)2524
2242014A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignanciesCHIA-CHI LIN ; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU ; Su W.-P.; KUN-HUEI YEH ; YEN-SHEN LU ; ANN-LII CHENG ; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; CHIH-HSIN YANG British Journal of Cancer6364
2252014Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverseSUNG-HSIN KUO ; Tsai H.-J.; Weng W.-H.; Li C.-C.; KUN-HUEI YEH ; Chen L.-T.; ANN-LII CHENG Genes Chromosomes and Cancer33
2262014Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensusANN-LII CHENG ; Li J.; Vaid A.K.; Ma B.B.Y.; Teh C.; Ahn J.B.; Bello M.; Charoentum C.; Chen L.-T.; De Lima Lopes G.; Jr.; Ho G.F.; Kong H.L.; Lam K.O.; Liu T.S.; Park Y.S.; Sriuranpong V.; Sudoyo A.W.; Wang J.-Y.; Zhang J.; Zhang S.Z.; Ciardiello F.; Köhne C.-H.; Shaw M.; Kim T.W.Clinical Colorectal Cancer1615
2272014Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancersHSIANG-FONG KAO ; I-CHUN CHEN ; CHIUN HSU ; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN ; Hu F.-C.; CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH Supportive Care in Cancer1010
2282014Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behaviorHuang W.-T.; SUNG-HSIN KUO ; ANN-LII CHENG ; CHUNG-WU LIN Modern Pathology1715
2292014Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancerYing-Chun Shen ; Li C.-P.; Yen C.-J.; CHIUN HSU ; Lin Y.-L.; ZHONG-ZHE LIN ; Chen L.-T.; Su W.-C.; Chao Y.; KUN-HUEI YEH ; ANN-LII CHENG Oncology (Switzerland)1512
2302014Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective studyCHIUN HSU ; Tsou H.-H.; Lin S.-J.; Wang M.-C.; MING YAO ; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; HWEI-FANG TIEN ; Liu T.-W.; PEI-JER CHEN ; ANN-LII CHENG Hepatology228210
2312014Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastasesYU-YUN SHAO ; MING-CHIH HO ; ANN-LII CHENG ; CHIH-HUNG HSU Journal of the Formosan Medical Association33
2322014Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphomaLiao F.; Hsu Y.-C.; SUNG-HSIN KUO ; Yang Y.-C.; Chen J.-P.; PING-NING HSU ; CHUNG-WU LIN ; Chen L.-T.; ANN-LII CHENG ; Fann C.S.J.; Lin J.-T.; MING-SHIANG WU Blood Cancer Journal2319
2332014Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivinDA-LIANG OU ; Lee B.-S.; LIANG-IN LIN ; Liou J.-Y.; Liao S.-C.; CHIUN HSU ; ANN-LII CHENG Molecular Cancer4133
2342014The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cellsLin Y.-H.; Chen B.Y.-H.; Lai W.-T.; Wu S.-F.; JIH-HWA GUH ; ANN-LII CHENG ; LIH-CHING HSU Naunyn-Schmiedeberg's Archives of Pharmacology3432
2352014Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapyJENNY LING-YU CHEN ; CHAO-YUAN HUANG ; YU-SEN HUANG ; RUEY-JIEN CHEN ; CHUN-WEI WANG ; YU-HSUAN CHEN ; CHIA-HSIEN CHENG ; ANN-LII CHENG ; SUNG-HSIN KUO Acta Obstetricia et Gynecologica Scandinavica5656
2362014No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifenWEI-WU CHEN ; Chen H.-M.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; Lai M.-S.; YEN-SHEN LU Breast Cancer Research and Treatment108
2372014Helicobacter pylori sensitizes TNF-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIPLin W.-C.; Tsai H.-F.; Liao H.-J.; Tang C.-H.; Wu Y.-Y.; Hsu P.-I.; ANN-LII CHENG ; PING-NING HSU Cell Death and Disease2119
2382014erratum: Oxidative stress enhances AXL-mediated cell migration through AKT1/Rac1-dependent mechanism (Free Radical Biology and Medicine (2013) 65 (1246-1256))Huang J.-S.; Cho C.-Y.; Hong C.-C.; Yan M.-D.; Hsieh M.-C.; Lay J.-D.; Lai G.-M.; ANN-LII CHENG ; Chuang S.-E.Free Radical Biology and Medicine00
2392014Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based studyCHING-HUNG LIN ; Chuang P.-Y.; CHUN-JU CHIANG ; YEN-SHEN LU ; ANN-LII CHENG ; WEN-HUNG KUO ; CHIUN-SHENG HUANG ; Lai M.-S.; You S.-L.; Tang C.-H.Oncologist3939
2402014Clinical activity of metronomic chemotherapy in liver cancersYU-YUN SHAO ; ANN-LII CHENG ; CHIH-HUNG HSU Metronomic Chemotherapy: Pharmacology and Clinical Applications00
2412014Recent advances in the prevention of hepatocellular carcinoma recurrenceLI-CHUN LU ; ANN-LII CHENG ; Poon R.T.P.Seminars in Liver Disease5044
2422014Strategy for Preventing Hepatitis B Reactivation in Patients With Resolved Hepatitis B Virus Infection After Rituximab-Containing Chemotherapy ReplyCHIUN HSU ; PEI-JER CHEN ; ANN-LII CHENG Hepatology00
2432014Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivitySUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; CHIUN HSU ; MING-SHIANG WU ; Tzeng Y.-S.; Tsai H.-J.; HSIU-PO WANG ; ANN-LII CHENG Blood Cancer Journal3432
2442014A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumorsGhamande S.; CHIA-CHI LIN ; Cho D.C.; Shapiro G.I.; Kwak E.L.; Silverman M.H.; Tseng Y.; Kuo M.-W.; Mach W.B.; Hsu S.-C.; Coleman T.; CHIH-HSIN YANG ; ANN-LII CHENG ; Ghalib M.H.; Chuadhary I.; Goel S.Investigational New Drugs2315
2452014Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapyLI-CHUN LU ; YU-YUN SHAO ; Chan S.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG Anticancer Research1210
2462014Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patientsLin Y.-.; YI-HSIN LIANG ; JIA-HUEI TSAI ; JAU-YU LIAU ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG PLoS ONE1716
2472014Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunityChen M.-L.; BO-SHIUN YAN ; Lu W.-C.; Chen M.-H.; SUNG-LIANG YU ; PAN-CHYR YANG ; ANN-LII CHENG International Journal of Cancer9894
2482014Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinomaDA-LIANG OU ; Chang C.-J.; YUNG-MING JENG ; Lin Y.-J.; ZHONG-ZHE LIN ; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; CHIUN HSU ; ANN-LII CHENG Journal of Gastroenterology and Hepatology (Australia)1113
2492014Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert PanelANN-LII CHENG ; Amarapurkar D.; Chao Y.; PEI-JER CHEN ; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W.Liver International7469
2502014Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancerKUO-HSING CHEN ; YU-YUN SHAO ; ZHONG-ZHE LIN ; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; KUN-HUEI YEH ; ANN-LII CHENG ; Lai M.-S.Oncologist2419
2512014Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapyYU-YUN SHAO ; CHIH-HORNG WU ; LI-CHUN LU ; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; CHIH-HUNG HSU ; ANN-LII CHENG Journal of Hepatology4648
2522013Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3CHAO YUAN HUANG ; Lin, Chen-Si; Tai, Wei-Tien; Hsieh, Chi-Ying; Shiau, Chung-Wai; ANN-LII CHENG ; Chen, Kuen-FengInternational journal of radiation oncology, biology, physics4443
2532013Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal CancerLin, Yu-Lin; JAU-YU LIAU ; SHAN-CHI YU ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG Translational oncology910
2542013Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cellsYan K.-H.; Lee L.-M.; Hsieh M.-C.; Yan M.-D.; Yao C.-J.; Chang P.-Y.; Chen T.-L.; Chang H.-Y.; ANN-LII CHENG ; Lai G.-M.; Chuang S.-E.Oncology Reports1819
2552013erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH Gastric Cancer00
2562013Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL studyJohnson P.J.; Qin S.; Park J.-W.; Poon R.T.P.; Raoul J.-L.; Philip P.A.; CHIH-HUNG HSU ; Hu T.-H.; Heo J.; Xu J.; Lu L.; Chao Y.; Boucher E.; Han K.-H.; Paik S.-W.; Robles-Aviña J.; Kudo M.; Yan L.; Sobhonslidsuk A.; Komov D.; Decaens T.; Tak W.-Y.; Jeng L.-B.; Liu D.; Ezzeddine R.; Walters I.; ANN-LII CHENG Journal of Clinical Oncology618595
2572013Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor PathwayDA-LIANG OU ; Lee B.-S.; Chang Y.-C.; LIANG-IN LIN ; Liou J.-Y.; CHIUN HSU ; ANN-LII CHENG PLoS ONE1011
2582013Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)Park J.-W.; Amarapurkar D.; Chao Y.; PEI-JER CHEN ; Geschwind J.-F.H.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; ANN-LII CHENG Liver International6960
2592013Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study GroupKim S.J.; CHIUN HSU ; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T.; Chng W.-J.; ANN-LII CHENG ; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S.European Journal of Cancer9890
2602013Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor sizeZHONG-ZHE LIN ; Shau W.-Y.; CHIUN HSU ; YU-YUN SHAO ; Yeh Y.-C.; Kuo R.N.-C.; CHIH-HUNG HSU ; CHIH-HSIN YANG ; ANN-LII CHENG ; Lai M.-S.PLoS ONE2624
2612013Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinomaLI-CHUN LU ; YU-YUN SHAO ; Kuo R.N.C.; ZHONG-ZHE LIN ; Yeh Y.-C.; Shau W.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG ; Lai M.-S.Cancer1111
2622013Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinomaYU-CHIEH TSAI ; Yeh C.-H.; KAI-YUAN TZEN ; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU ; ANN-LII CHENG ; CHIA-HSIEN CHENG European Journal of Cancer2624
2632013Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of ProteasomeYu H.-C.; Hou D.-R.; Liu C.-Y.; Lin C.-S.; Shiau C.-W.; ANN-LII CHENG ; Chen K.-F.PLoS ONE4193
2642013Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinomaYu H.-C.; Chen H.-J.; Chang Y.-L.; Liu C.-Y.; Shiau C.-W.; ANN-LII CHENG ; Chen K.-F.Biochemical Pharmacology4544
2652013Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapyWEI-WU CHEN ; CHIA-CHI LIN ; TA-CHEN HUANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU Anticancer Research1111
2662013The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclinesWEI-WU CHEN ; DWANG-YING CHANG ; Huang S.-M.; CHING-HUNG LIN ; CHIUN HSU ; Lin M.-H.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; ANN-LII CHENG Breast45
2672013Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinomaYing-Chun Shen ; DA-LIANG OU ; CHIUN HSU ; Lin K.-L.; Chang C.-Y.; CHING-YU LIN ; Liu S.-H.; ANN-LII CHENG British Journal of Cancer155146
2682013Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II studyCHIH-HUNG HSU ; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN ; YU-YUN SHAO ; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU ; ANN-LII CHENG Oncology (Switzerland)4041
2692013Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyUeno H.; Ioka T.; Ikeda M.; Ohkawa S.; Yanagimoto H.; Boku N.; Fukutomi A.; Sugimori K.; Baba H.; Yamao K.; Shimamura T.; Sho M.; Kitano M.; ANN-LII CHENG ; Mizumoto K.; Chen J.-S.; Furuse J.; Funakoshi A.; Hatori T.; Yamaguchi T.; Egawa S.; Sato A.; Ohashi Y.; Okusaka T.; Tanaka M.; 鄭安理Journal of Clinical Oncology508467
2702013Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomasWu P.-F.; Huang W.-C.; CHIH-HSIN YANG ; YEN-SHEN LU ; JIN-YUAN SHIH ; SHANG-GIN WU ; CHING-HUNG LIN ; ANN-LII CHENG Journal of Neuro-Oncology85
2712013The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinomaYU-YUN SHAO ; Chang Y.-L.; Huang C.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG Oncology (Switzerland)55
2722013Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisationCHING-HUNG LIN ; Liu J.M.; YEN-SHEN LU ; Lan C.; Lee W.-C.; KUAN-TING KUO ; Wang C.-C.; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG Journal of Clinical Pathology1314
2732013Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significanceSUNG-HSIN KUO ; Chen L.-T.; CHUNG-WU LIN ; MING-SHIANG WU ; PING-NING HSU ; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG Blood Cancer Journal3836
2742013CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancerSUNG-HSIN KUO ; Yang, Shi-Yi; HUANG-CHUN LIEN ; Chiao Lo ; CHING-HUNG LIN ; YEN-SHEN LU ; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG BioMed Research International99
2752013Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trialANN-LII CHENG ; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E.Journal of Clinical Oncology619599
2762013The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma MultiformeLee P.-Y.; Chen C.-L.; ZHONG-ZHE LIN ; ANN-LII CHENG ; Chen E.I.-T.; Whang-Peng J.; Huang C.-Y.F.Oncology119
2772013Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibodyChen K.-F.; Chen H.-L.; Shiau C.-W.; Liu C.-Y.; Chu P.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN ; ANN-LII CHENG British Journal of Pharmacology1613
2782013Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cellsTai W.-T.; Shiau C.-W.; Chen H.-L.; Liu C.-Y.; Lin C.-S.; ANN-LII CHENG ; PEI-JER CHEN ; Chen K.-F.Cell Death and Disease159159
2792013Clinicopathologic features and responses to radiotherapy of myeloid sarcomaWAN-YU CHEN ; CHUN-WEI WANG ; Chang C.-H.; Liu H.-H.; KENG-HSUEH LAN ; JIH-LUH TANG ; HWEI-FANG TIEN ; SUNG-HSIN KUO ; ANN-LII CHENG Radiation Oncology2525
2802013Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanismHuang J.-S.; Cho C.-Y.; Hong C.-C.; Yan M.-D.; Hsieh M.-C.; Lay J.-D.; Lai G.-M.; ANN-LII CHENG ; Chuang S.-E.Free Radical Biology and Medicine4639
2812013Helicobacter pylori and mucosa-associated lymphoid tissue: what's newSUNG-HSIN KUO ; ANN-LII CHENG Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program4543
2822013No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A replySUNG-HSIN KUO ; Weng W.-H.; KUN-HUEI YEH ; Chen L.-T.; ANN-LII CHENG Genes Chromosomes and Cancer11
2832013Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: Complete response to combined intrathecal and systemic rituximabHUAI-CHENG HUANG ; ANN-LII CHENG ; CHUNG-WU LIN ; SUNG-HSIN KUO Annals of Hematology54
2842013A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapyYU-YUN SHAO ; PO-CHIN LIANG ; YAO-MING WU ; Huang C.-C.; KAI-WEN HUANG ; CHIA-HSIEN CHENG ; CHIH-HUNG HSU ; CHIUN HSU ; ANN-LII CHENG ; ZHONG-ZHE LIN Liver International1515
2852013Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κb is associated with a poor prognosis of pancreatic cancerSHIH-HUNG YANG ; CHIH-HUNG HSU ; JEN-CHIEH LEE ; YU-WEN TIEN ; SUNG-HSIN KUO ; ANN-LII CHENG Oncology (Switzerland)2420
2862012BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavageJou, Shin-Yi; Chang, Chien-Chih; Wu, Chun-Hsien; MEI-RU CHEN ; CHING-HWA TSAI ; Chuang, Wen-Hui; Chen, Yun-Hui; ANN-LII CHENG ; SHIN-LIAN DOONG Journal of biomedical science2
2872012Primary squamous cell carcinoma of the thyroid with cardiac metastases and right ventricle outflow tract obstructionKUO-HSING CHEN ; Chou Y.-H.; ANN-LII CHENG Journal of Clinical Oncology1412
2882012Targeting fibroblast growth factor receptor signaling in hepatocellular carcinomaANN-LII CHENG ; Ying-Chun Shen ; Zhu A.X.Oncology3941
2892012Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systemsYU-YUN SHAO ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; Ying-Chun Shen ; CHIH-HUNG HSU ; ANN-LII CHENG British Journal of Cancer2626
2902012CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cellsLin Y.-C.; Chen K.-C.; CHING-CHOW CHEN ; ANN-LII CHENG ; Chen K.-F.Oral Oncology5453
2912012Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapyYU-YUN SHAO ; Huang C.-C.; Lin S.-D.; CHIH-HUNG HSU ; ANN-LII CHENG Clinical Cancer Research3937
2922012Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinomaYen C.-H.; Lu Y.-C.; Li C.-H.; Lee C.-M.; Chen C.-Y.; Cheng M.-Y.; Huang S.-F.; Chen K.-F.; ANN-LII CHENG ; Liao L.-Y.; Lee Y.-H.W.; Chen Y.-M.A.Molecular Medicine5248
2932012Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signalingSUNG-HSIN KUO ; Chou C.-H.; ANN-LII CHENG ; CHUN-WEI WANG ; YU-HSUAN CHEN ; RUEY-JIEN CHEN Gynecologic Oncology1918
2942012KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer CellsLin Y.-L.; JAU-YU LIAU ; SHAN-CHI YU ; DA-LIANG OU ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG PLoS ONE4435
2952012Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cellsLin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Chung S.-H.; Chen K.-F.; ANN-LII CHENG ; CHING-CHOW CHEN Neoplasia (United States)3736
2962012Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinomaYU-YUN SHAO ; ZHONG-ZHE LIN ; CHIUN HSU ; Lee, Kuan-Der; Hsiao, Chi-Huang; YEN-SHEN LU ; Huang, Chien-Chung; YING-CHUN SHEN ; CHIH-HUNG HSU ; ANN-LII CHENG Oncology2625
2972012Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomasSUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; PING-NING HSU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG Blood11593
2982012Medulloblastoma in adults: Treatment outcome, relapse patterns, and prognostic factorsSHIH-FAN LAI ; CHUN-WEI WANG ; YU-HSUAN CHEN ; KENG-HSUEH LAN ; CHIA-HSIEN CHENG ; ANN-LII CHENG ; SUNG-HSIN KUO Strahlentherapie und Onkologie1211
2992012Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trialANN-LII CHENG ; Guan Z.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Yang T.-S.; Tak W.Y.; Pan H.; Yu S.; Xu J.; Fang F.; Zou J.; Lentini G.; Voliotis D.; Kang Y.-K.European Journal of Cancer220212
3002012Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regressionCHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH Gastric Cancer1918
3012012Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphomaSHIH-HUNG YANG ; Lin L.-W.; YU-JEN FANG ; ANN-LII CHENG ; SUNG-HSIN KUO Annals of Hematology62
3022012Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancerLI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; CHIUN HSU ; WEN-FANG CHENG ; YU-LIN LIN ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research0
3032012Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN ; ANN-LII CHENG Biochemical Pharmacology4035
3042012A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-RegressionYING-CHUN SHEN ; CHIUN HSU ; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG Oncology3429
3052012Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN ; Chen K.-F.Molecular Cancer Therapeutics112108
3062012Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled studyCHIUN HSU ; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; CHIH-WEI YU ; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG Journal of Hepatology7974
3072012Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study GroupKim, Seok Jin; Moon, Joon Ho; Kim, Hawk; Kim, Jin Seok; Hwang, Yu Yan; Intragumtornchai, Tanin; Issaragrisil, Surapol; Kwak, Jae Yong; Lee, Je Jung; Won, Jong Ho; Reksodiputro, Arry Harryanto; Lim, Soon Thye; ANN-LII CHENG ; Kim, Won Seog; Kwong, Yok LamLeukemia & Lymphoma3226
3082012Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapyKuo Y.-H.; CHING-HUNG LIN ; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG ; Huang S.-M.; CHIUN HSU ; YEN-SHEN LU ; ANN-LII CHENG BMC Cancer1916
3092012Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWEN-HUNG KUO ; PO-HAN LIN ; Huang A.-C.; YIN-HSIU CHIEN ; Liu T.-P.; YEN-SHEN LU ; Bai L.-Y.; Sargeant A.M.; CHING-HUNG LIN ; ANN-LII CHENG ; FON-JOU HSIEH ; WUH-LIANG HWU ; KING-JEN CHANG Journal of Human Genetics1919
3102012Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinomaShau W.-Y.; YU-YUN SHAO ; Yeh Y.-C.; ZHONG-ZHE LIN ; Kuo R.; CHIH-HUNG HSU ; CHIUN HSU ; ANN-LII CHENG ; Lai M.-S.Oncologist3232
3112012Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cellsChen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN ; ANN-LII CHENG Biochemical Pharmacology5050
3122012Management of colon cancer: Resource-stratified guidelines from the Asian Oncology Summit 2012Ku G.; Tan I.B.; Yau T.; Boku N.; Laohavinij S.; ANN-LII CHENG ; Kang Y.-K.; de Lima Lopes G.The Lancet Oncology6661
3132012Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinomaYU-YUN SHAO ; Chen C.-L.; MING-CHIH HO ; Huang C.-C.; Tu H.-C.; CHIH-HUNG HSU ; ANN-LII CHENG Anticancer Research910
3142012The impact of diabetes mellitus on prognosis of early breast cancer in AsiaWEI-WU CHEN ; YU-YUN SHAO ; Shau W.-Y.; ZHONG-ZHE LIN ; YEN-SHEN LU ; Chen H.-M.; Kuo R.N.C.; ANN-LII CHENG ; Lai M.-S.Oncologist3634
3152012Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapyZHONG-ZHE LIN ; CHIUN HSU ; Hu F.-C.; YU-YUN SHAO ; DWANG-YING CHANG ; CHIH-HSIN YANG ; RUEY-LONG HONG ; CHIH-HUNG HSU ; ANN-LII CHENG Oncologist810
3162012Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinomaYEN-SHEN LU ; Chou C.-H.; KAI-YUAN TZEN ; Gao M.; ANN-LII CHENG ; Kulp S.K.; CHIA-HSIEN CHENG International Journal of Radiation Oncology Biology Physics2120
3172012The emerging epidemic of estrogen-related cancers in young women in a developing Asian countryCHING-HUNG LIN ; Chen Y.-C.; CHUN-JU CHIANG ; YEN-SHEN LU ; KUAN-TING KUO ; CHIUN-SHENG HUANG ; WEN-FANG CHENG ; Lai M.-S.; You S.-L.; ANN-LII CHENG International Journal of Cancer4745
3182012Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2ACHAO YUAN HUANG ; CHIA-CHENG WEI ; Chen K.-C.; Chen H.-J.; ANN-LII CHENG ; Chen K.-F.Cancer Letters2928
3192011High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapyYU-YUN SHAO ; ZHONG-ZHE LIN ; Chen T.-J.; CHIUN HSU ; Ying-Chun Shen ; CHIH-HUNG HSU ; ANN-LII CHENG Oncology1717
3202011Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II studyCh'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG ; Chiu Y.-F.; MING-CHU CHANG ; CHIH-HUNG HSU ; YU-WEN TIEN ; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG ; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.International Journal of Radiation Oncology Biology Physics1917
3212011IκB kinases increase Myc protein stability and enhance progression of breast cancer cellsYeh P.-Y.; YEN-SHEN LU ; DA-LIANG OU ; ANN-LII CHENG Molecular Cancer2423
3222011Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancersHo Y.-F.; Lu W.-C.; Chen R.R.-L.; ANN-LII CHENG ; KUN-HUEI YEH Anti-Cancer Drugs53
3232011T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvementSUNG-HSIN KUO ; ANN-LII CHENG ; CHUNG-WU LIN ; CHIH-HUNG HSU ; MING-SHIANG WU ; KUN-HUEI YEH ; Tzeng Y.-S.; Chen L.-T.Cancer Chemotherapy and Pharmacology138
3242011Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphomaSUNG-HSIN KUO ; Weng W.-H.; Chen Z.-H.; PING-NING HSU ; MING-SHIANG WU ; CHUNG-WU LIN ; Jeng H.-J.; KUN-HUEI YEH ; Tsai H.-J.; Chen L.-T.; ANN-LII CHENG Genes Chromosomes and Cancer79
3252011A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in TaiwanChen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG ; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH ; Chen L.-T.; Whang-Peng J.Cancer Chemotherapy and Pharmacology65
3262011Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cellsRodriguez B.A.T.; Weng Y.-I.; Liu T.-M.; Zuo T.; Hsu P.-Y.; CHING-HUNG LIN ; ANN-LII CHENG ; Cui H.; Yan P.S.; Huang T.H.-M.Carcinogenesis4035
3272011Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinomaTai W.-T.; ANN-LII CHENG ; Shiau C.-W.; HSIANG-PO HUANG ; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology146140
3282011Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of RafChen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; ANN-LII CHENG ; PEI-JER CHEN ; Shiau C.-W.European Journal of Medicinal Chemistry3229
3292011Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG Journal of Clinical Pathology88
3302011Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001SUNG-HSIN KUO ; CHIH-HUNG HSU ; Chen L.-T.; YEN-SHEN LU ; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH ; ANN-LII CHENG European Journal of Cancer1717
3312011Recent advances in the treatment of metastatic colorectal cancer in TaiwanLin Y.-L.; KUN-HUEI YEH ; ANN-LII CHENG Journal of the Formosan Medical Association11
3322011Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracilCHAO-YU HSU ; Ying-Chun Shen ; CHIH-WEI YU ; CHIUN HSU ; Hu F.-C.; CHIH-HUNG HSU ; BANG-BIN CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH Journal of Hepatology106100
3332011Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trialsSHIH-HUNG YANG ; Kuo Y.-H.; YU-WEN TIEN ; CHIUN HSU ; CHIH-HUNG HSU ; SUNG-HSIN KUO ; ANN-LII CHENG Oncology1313
3342011Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapyYU-YUN SHAO ; LI-CHUN LU ; ANN-LII CHENG ; CHIH-HUNG HSU Oncologist3428
3352011Antiangiogenic strategies for the treatment of hepatocellular carcinomaCHIUN HSU ; Ying-Chun Shen ; ANN-LII CHENG Targeted Therapies for Hepatocellular Carcinoma00
3362011Needs for hepatocellular carcinoma control policy in the Asia-Pacific regionBridges J.F.P.; Joy S..; Gallego G.; Kudo M.; Ye S.-L.; Han K.-H.; ANN-LII CHENG ; Blauvelt B.Asian Pacific Journal of Cancer Prevention25
3372011Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinomaYU-YUN SHAO ; PEI-JER CHEN ; ZHONG-ZHE LIN ; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; CHIH-HUNG HSU ; ANN-LII CHENG Anticancer Research12
3382011Asian consensus workshop report: Expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in AsiaHan K.-H.; Kudo M.; Ye S.-L.; Choi J.Y.; Poon R.T.-P.; Seong J.; Park J.-W.; Ichida T.; Chung J.W.; Chow P.; ANN-LII CHENG Oncology9898
3392011Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinibHarmon C.S.; DePrimo S.E.; Raymond E.; ANN-LII CHENG ; Boucher E.; Douillard J.-Y.; Lim H.Y.; Kim J.S.; Lechuga M.J.; Lanzalone S.; Lin X.; Faivre S.Journal of Translational Medicine2120
3402011Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2AChen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG Molecular Cancer Therapeutics3632
3412011Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cellsChen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; CHIH-HUNG HSU ; PEI-JER CHEN ; ANN-LII CHENG Journal of Pharmacology and Experimental Therapeutics265254
3422011Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinibFaivre S.; Zappa M.; Vilgrain V.; Boucher E.; Douillard J.-Y.; Lim H.Y.; Kim J.S.; Im S.-A.; Kang Y.-K.; Bouattour M.; Dokmak S.; Dreyer C.; Sablin M.-P.; Serrate C.; ANN-LII CHENG ; Lanzalone S.; Lin X.; Lechuga M.J.; Raymond E.Clinical Cancer Research7367
3432011Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern eraI-CHUN CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; HUANG-CHUN LIEN ; CHIUN HSU ; WEN-HUNG KUO ; YEN-SHEN LU ; ANN-LII CHENG Breast Cancer Research and Treatment8774
3442010The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cellsYan K.-H.; Yao C.-J.; Chang H.-Y.; Lai G.-M.; ANN-LII CHENG ; Chuang S.-E.Molecular Carcinogenesis4539
3452010Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphomaSUNG-HSIN KUO ; RUOH-FANG YEN ; CHUNG-WU LIN ; Chen L.-T.; HWEI-FANG TIEN ; ANN-LII CHENG Annals of Hematology11
3462010Clinical Development and Future Direction for the Treatment of Hepatocellular CarcinomaWhang-Peng J.; ANN-LII CHENG ; CHIUN HSU ; Chen C.-M.Journal of Experimental and Clinical Medicine250
3472010Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial designCHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG Contemporary Clinical Trials4137
3482010Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cellsWeng Y.-I.; Hsu P.-Y.; Liyanarachchi S.; Liu J.; Deatherage D.E.; Huang Y.-W.; Zuo T.; Rodriguez B.; CHING-HUNG LIN ; ANN-LII CHENG ; Huang T.H.-M.Toxicology and Applied Pharmacology10887
3492010Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapyCHING-HUNG LIN ; HUANG-CHUN LIEN ; Hu F.-C.; YEN-SHEN LU ; SUNG-HSIN KUO ; Wu L.-C.; You S.-L.; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG Journal of Zhejiang University: Science B811
3502010Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approachYing-Chun Shen ; CHIUN HSU ; Chen L.-T.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG Journal of Hepatology124113
3512010Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinomaCHIH-HUNG HSU ; Ying-Chun Shen ; ZHONG-ZHE LIN ; PEI-JER CHEN ; YU-YUN SHAO ; Ding Y.-H.; CHIUN HSU ; ANN-LII CHENG Journal of Hepatology110103
3522010E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: Possible correlation with stage and treatment responseLiu T.-Y.; SHEE-UAN CHEN ; SUNG-HSIN KUO ; ANN-LII CHENG ; CHUNG-WU LIN Modern Pathology4340
3532010Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cellsDA-LIANG OU ; Ying-Chun Shen ; SUNG-LIANG YU ; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; LIANG-IN LIN ; CHIUN HSU ; ANN-LII CHENG Cancer Research7069
3542010Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivationChen K.-F.; Yu H.-C.; TSUNG-HAO LIU ; SHOEI-SHENG LEE ; PEI-JER CHEN ; ANN-LII CHENG Journal of Hepatology6867
3552010CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cellsChen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; TSUNG-HAO LIU ; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG Oncogene148139
3562010Molecular targeted therapy for advanced hepatocellular carcinoma: Current status and future perspectivesYing-Chun Shen ; CHIUN HSU ; ANN-LII CHENG Journal of Gastroenterology6254
3572010Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatinYU-YUN SHAO ; KUAN-TING KUO ; Hu F.-C.; YEN-SHEN LU ; CHIUN-SHENG HUANG ; JAU-YU LIAU ; Lee W.-C.; CHIUN HSU ; WEN-HUNG KUO ; KING-JEN CHANG ; CHING-HUNG LIN ; ANN-LII CHENG Japanese Journal of Clinical Oncology2824
3582010Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphomaChiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO ; CHIH-HUNG HSU ; YEN-SHEN LU ; ANN-LII CHENG Cancer Letters1919
3592010Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinomaCHIH-HUNG HSU ; Yang T.-S.; CHIUN HSU ; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN ; ZHONG-ZHE LIN ; Chao T.-Y.; ANN-LII CHENG British Journal of Cancer114112
3602010Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinomaOmata M.; Lesmana L.A.; Tateishi R.; PEI-JER CHEN ; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG ; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K.Hepatology International881860
3612010Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3Chen K.-F.; Tai W.-T.; TSUNG-HAO LIU ; HSIANG-PO HUANG ; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN ; ANN-LII CHENG Clinical Cancer Research147145
3622010O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancersPEI-FANG WU; KUAN-TING KUO ; LU-TING KUO ; YI-TING LIN; WEI-CHUNG LEE; YEN-SHEN LU ; CHIH-HSIN YANG ; RUEY-MEEI WU ; YONG-KWANG TU ; JUI-CHANG TASI ; HAM-MIN TSENG; SHENG-HONG TSENG ; ANN-LII CHENG ; CHING-HUNG LIN Lung Cancer2626
3632010Translocation of Helicobacter pylori CagA into human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphomaLin W.-C.; Tsai H.-F.; SUNG-HSIN KUO ; MING-SHIANG WU ; CHUNG-WU LIN ; Hsu P.-I.; ANN-LII CHENG ; PING-NING HSU Cancer Research8069
3642010Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinomaYU-YUN SHAO ; ZHONG-ZHE LIN ; CHIUN HSU ; Ying-Chun Shen ; CHIH-HUNG HSU ; ANN-LII CHENG Cancer141148
3652010Characteristics and risk factors of oxaliplatin-related hypersensitivity reactionsYU-YUN SHAO ; Hu F.-C.; JIN-TUNG LIANG ; Chiu W.-T.; ANN-LII CHENG ; CHIH-HSIN YANG Journal of the Formosan Medical Association2723
3662010Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCCZHONG-ZHE LIN ; YUNG-MING JENG ; Hu F.-C.; Pan H.-W.; Tsao H.-W.; Lai P.; PO-HUANG LEE ; ANN-LII CHENG ; Hsu H.-C.BMC Cancer10298
3672010Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulationPO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research64
3682010Liver cancer working group reportKudo M.; Han K.H.; Kokudo N.; ANN-LII CHENG ; Choi B.I.; Furuse J.; Izumi N.; Park J.-W.; Poon R.T.; Sakamoto M.Japanese Journal of Clinical Oncology5453
3692009Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatmentYU-YUN SHAO ; ZHONG-ZHE LIN ; PO-CHIN LIANG ; YU-WEN TIEN ; ANN-LII CHENG Anticancer Research11
3702009Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphomaSHIH-HUNG YANG ; ZHONG-ZHE LIN ; SUNG-HSIN KUO ; ANN-LII CHENG American Journal of Hematology11
3712009Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patientsCHIEN-HUNG CHEN ; Hu F.-C.; GUAN-TARN HUANG ; PO-HUANG LEE ; Tsang Y.-M.; ANN-LII CHENG ; DING-SHINN CHEN ; Wang J.-D.; JIN-CHUAN SHEU European Journal of Cancer6864
3722009Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder CancerCHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Feng-Ming Hsu ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU International Journal of Radiation Oncology Biology Physics2722
3732009Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathwayChen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG Journal of Biological Chemistry8984
3742009National Center of Excellence for Clinical Trials and Research at National Taiwan University HospitalCHIA-CHI LIN ; CHIH-HSIN YANG ; ANN-LII CHENG ; Chan W.-K.; HONG-NERNG HO Drug Information Journal32
3752009Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II studyFaivre S.; Raymond E.; Boucher E.; Douillard J.; Lim H.Y.; Kim J.S.; Zappa M.; Lanzalone S.; Lin X.; DePrimo S.; Harmon C.; Ruiz-Garcia A.; Lechuga M.J.; ANN-LII CHENG The Lancet Oncology257232
3762009Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast - A review of 42 primary and secondary cases in Taiwanese patientsLin Y.-C.; Tsai C.-H.; Wu J.-S.; CHIUN-SHENG HUANG ; SUNG-HSIN KUO ; CHUNG-WU LIN ; ANN-LII CHENG Leukemia and Lymphoma2821
3772009EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatmentHuang C.-L.; CHIH-HSIN YANG ; KUN-HUEI YEH ; Hu F.-C.; KUAN-YU CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; ANN-LII CHENG ; PAN-CHYR YANG Lung Cancer4336
3782009Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapyCHIUN HSU ; SHU-CHEN WEI ; ANN-LII CHENG ; PEI-JER CHEN Hepatology43
3792009The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinomaZHONG-ZHE LIN ; Hsu H.-C.; CHIH-HUNG HSU ; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; SUNG-HSIN KUO ; CHIUN HSU ; Hu F.-C.; YUNG-MING JENG ; Chung Y.; ANN-LII CHENG Journal of Hepatology3939
3802009Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in AsiaCHING-HUNG LIN ; JAU-YU LIAU ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Lee W.-C.; KUAN-TING KUO ; Ying-Chun Shen ; SUNG-HSIN KUO ; Lan C.; Liu J.M.; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG Cancer Epidemiology Biomarkers and Prevention10195
3812009Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancerCh'ang H.-J.; Huang C.-L.; HSIU-PO WANG ; Shiah H.-S.; MING-CHU CHANG ; Jan C.-M.; Chen J.-S.; YU-WEN TIEN ; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG ; Whang-Peng J.; Chen L.-T.Cancer Chemotherapy and Pharmacology1313
3822009Sorafenib for the treatment of hepatocellular carcinoma across geographic regionsCHIUN HSU ; Ying-Chun Shen ; ANN-LII CHENG Expert review of Clinical Pharmacology100
3832009Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survivalYing-Chun Shen ; Hu F.-C.; YUNG-MING JENG ; YU-TING CHANG ; ZHONG-ZHE LIN ; MING-CHU CHANG ; CHIUN HSU ; ANN-LII CHENG Cancer Epidemiology Biomarkers and Prevention2120
3842009Lamivudine and hepatitis B reactivationCHIUN HSU ; ANN-LII CHENG ; PEI-JER CHEN Annals of Internal Medicine00
3852009Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinomaDA-LIANG OU ; Ying-Chun Shen ; JA-DER LIANG ; Liou J.-Y.; SUNG-LIANG YU ; Fan H.-H.; Wang D.-S.; YEN-SHEN LU ; CHIUN HSU ; ANN-LII CHENG Clinical Cancer Research3234
3862009Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialANN-LII CHENG ; Kang Y.-K.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Luo R.; Feng J.; Ye S.; Yang T.-S.; Xu J.; Sun Y.; Liang H.; Liu J.; Wang J.; Tak W.Y.; Pan H.; Burock K.; Zou J.; Voliotis D.; Guan Z.The Lancet Oncology48994547
3872009Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling PathwayChou C.H.; PEI-JER CHEN ; YUNG-MING JENG ; ANN-LII CHENG ; Huang L.-R.; CHIA-HSIEN CHENG International Journal of Radiation Oncology Biology Physics2323
3882009Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical applicationJIH-HSIANG LEE ; ANN-LII CHENG ; CHUNG-WU LIN ; SUNG-HSIN KUO British Journal of Dermatology129
3892008Histone deacetylase inhibitors in cancer therapySargeant, Aaron M.; Kulp, Samuel K.; YEN-SHEN LU ; ANN-LII CHENG ; Chen, Ching ShihCancer Epigenetics0
3902008OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinomaGao M.; Yeh P.Y.; YEN-SHEN LU ; CHIH-HUNG HSU ; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG Cancer Research131123
3912008Organization-based performance measures of cancer care quality: Core measure development for breast cancer in TaiwanChung K.-P.; Lai M.-S.; Cheng S.H.; Tang S.-T.; Huang C.C.; ANN-LII CHENG ; Hsieh P.-C.European Journal of Cancer Care2624
3922008Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathwayDai H.-Y.; Hong C.-C.; Liang S.-C.; Yan M.-D.; Lai G.-M.; ANN-LII CHENG ; Chuang S.-E.Molecular Carcinogenesis3935
3932008Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cellsLin H.-J.L.; Zuo T.; CHING-HUNG LIN ; Chieh T.K.; Liyanarachchi S.; Sun S.; Shen R.; Deatherage D.E.; Potter D.; Asamoto L.; Lin S.; Yan P.S.; ANN-LII CHENG ; Ostrowski M.C.; Huang T.H.-M.Cancer Research5855
3942008Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatmentSUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; CHUNG-WU LIN ; KUN-HUEI YEH ; KUAN-TING KUO ; Yeh P.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; PING-NING HSU ; Lin J.-T.; ANN-LII CHENG Annals of Surgery1413
3952008Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cellsChen K.-F.; Yeh P.-Y.; KUN-HUEI YEH ; YEN-SHEN LU ; SHANG-YI HUANG ; ANN-LII CHENG Cancer Research114105
3962008A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trialCHIUN HSU ; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; HWEI-FANG TIEN ; Chao T.-Y.; Liu T.-W.; ANN-LII CHENG ; PEI-JER CHEN Hepatology273243
3972008Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatmentZHONG-ZHE LIN ; CHIUN HSU ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HUNG HSU ; CHIA-CHI LIN ; ANN-LII CHENG ; PAN-CHYR YANG ; CHIH-HSIN YANG Lung Cancer51
3982008NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cellsGao M.; Yeh P.Y.; YEN-SHEN LU ; Chang W.C.; Kuo M.-L.; ANN-LII CHENG Biochemical and Biophysical Research Communications2319
3992008Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapyCHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN ; ZHONG-ZHE LIN ; Huang C.-J.; CHIA-TUNG SHUN ; Huang C.-L.; Bean J.; ANN-LII CHENG ; Pao W.; PAN-CHYR YANG Journal of Clinical Oncology240224
4002008Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemiaHong C.-C.; Lay J.-D.; Huang J.-S.; ANN-LII CHENG ; JIH-LUH TANG ; Lin M.-T.; Lai G.-M.; Chuang S.-E.Cancer letters184165
4012008Disseminated peritoneal leiomyomatosis responds to systemic chemotherapyLin Y.-C.; LING-HUNG WEI ; CHIA-TUNG SHUN ; ANN-LII CHENG ; CHIH-HUNG HSU Oncology2820
4022008Comprehensive Locoregional Treatment and Systemic Therapy for Postmastectomy Isolated Locoregional RecurrenceSUNG-HSIN KUO ; CHIUN-SHENG HUANG ; WEN-HUNG KUO ; ANN-LII CHENG ; KING-JEN CHANG ; CHIA-HSIEN CHENG International Journal of Radiation Oncology Biology Physics4033
4032008Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinomaCHIA-CHI LIN ; YEONG-SHIAU PU ; CHIH-HUNG HSU ; Keng H.-Y.; ANN-LII CHENG ; CHIH-HSIN YANG Urologic Oncology: Seminars and Original Investigations87
4042008FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C δ signalingHung J.-H.; YEN-SHEN LU ; Wang Y.-C.; Ma Y.-H.; Wang D.-S.; Kulp S.K.; Muthusamy N.; Byrd J.C.; ANN-LII CHENG ; Chen C.-S.Cancer Research9693
4052008Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trialCHIUN HSU ; SUNG-HSIN KUO ; Hu F.-C.; ANN-LII CHENG ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIA-CHI LIN ; Huang T.-C.; PAN-CHYR YANG ; CHIH-HSIN YANG Lung Cancer1411
4062008Sorafenib benefits Asian patients with advanced HCCANN-LII CHENG Oncology Report0
4072008Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulationTA-CHEN HUANG ; KUN-HUEI YEH ; ANN-LII CHENG ; CHIH-HUNG HSU Anticancer Research159
4082008Differential expression of glucocorticoid receptor in carcinomas of the human digestive systemHUANG-CHUN LIEN ; YEN-SHEN LU ; CHIA-TUNG SHUN ; Yao Y.-T.; Chang W.-C.; ANN-LII CHENG Histopathology1817
4092008Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphomaSUNG-HSIN KUO ; Yeh P.-Y.; Chen L.-T.; MING-SHIANG WU ; CHUNG-WU LIN ; KUN-HUEI YEH ; Tzeng Y.-S.; Chen J.-Y.; PING-NING HSU ; Lin J.-T.; ANN-LII CHENG Blood4647
4102008Prognostic factors in extrapulmonary small cell carcinomas: A large retrospective studyLin Y.-L.; Chung C.-Y.; Chang C.-S.; Wu J.-S.; KUAN-TING KUO ; SUNG-HSIN KUO ; ANN-LII CHENG Oncology2017
4112007Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 yearsSHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WEN-CHUNG LEE ; WOEI TSAY ; ANN-LII CHENG ; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN Cancer8471
4122007Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancerCHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; JANG-MING LEE ; KUN-HUEI YEH ; CHIH-HSIN YANG ; Lin J.-T.; ANN-LII CHENG ; Lee Y.-C.Annals of Oncology3936
4132007Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinomaCHIA-CHI LIN ; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIUN HSU ; YU-CHIEH TSAI ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HUNG HSU Anti-Cancer Drugs108
4142007Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trialCHIA-CHI LIN ; CHIH-HUNG HSU ; Hour T.-C.; ANN-LII CHENG ; CHAO-YUAN HUANG ; KUO-HOW HUANG ; Chen J.; YEONG-SHIAU PU Urologic Oncology: Seminars and Original Investigations66
4152007A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinomaChen Y.-M.; CHONG-JEN YU ; CHIH-HSIN YANG ; Perng R.-P.; Tsai C.-M.; Shih J.-F.; ANN-LII CHENG ; Lefresne F.; Barbier M.; Pouget J.-C.; PAN-CHYR YANG Lung Cancer1412
4162007Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based RegimensCHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU Urology2421
4172007Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trialCHIA-CHI LIN ; CHIUN HSU ; CHIH-HUNG HSU ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HSIN YANG Investigational New Drugs105103
4182007Clinical studies with curcuminCHIH-HUNG HSU ; ANN-LII CHENG Advances in Experimental Medicine and Biology360305
4192007Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expressionSUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; KUAN-TING KUO ; KUN-HUEI YEH ; SHIN-LIAN DOONG ; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; CHUNG-WU LIN ; Lin J.-T.; ANN-LII CHENG Journal of Pathology1911
4202007Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaYEN-SHEN LU ; Kashida Y.; Kulp S.K.; Wang Y.-C.; Wang D.; Hung J.-H.; Tang M.; ZHONG-ZHE LIN ; Chen T.-J.; ANN-LII CHENG ; Chen C.-S.Hepatology8383
4212007Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II studyCHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; Keng H.-Y.; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU Anti-Cancer Drugs3229
4222007Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cellsChia H.C.; PEI-JER CHEN ; PO-HUANG LEE ; ANN-LII CHENG ; Hsu H.-C.; CHIA-HSIEN CHENG Clinical Cancer Research8978
4232007Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXLLay J.-D.; Hong C.-C.; Huang J.-S.; Yang Y.-Y.; Pao C.-Y.; Liu C.-H.; Lai Y.-P.; Lai G.-M.; ANN-LII CHENG ; Su I.-J.; Chuang S.-E.Cancer Research9786
4242007A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancerCHIA-CHI LIN ; ANN-LII CHENG ; CHIH-HUNG HSU ; YEN-SHEN LU ; CHIUN HSU ; KUN-HUEI YEH ; Wu C.-Y.; CHIUN-SHENG HUANG ; CHIH-HSIN YANG Anticancer Research22
4252007Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial CarcinomaCHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; ANN-LII CHENG ; Vogelzang N.J.; YEONG-SHIAU PU Journal of Urology2018
4262007Molecular targeted therapy for advanced hepatocellular carcinomaYing-Chun Shen ; CHIUN HSU ; ANN-LII CHENG Targeted Oncology64
4272006Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancerShiah H.-S.; ANN-LII CHENG ; CHIUN HSU ; CHIH-HUNG HSU ; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T.Journal of Gastroenterology and Hepatology (Australia)65
4282006Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivityYEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; SUNG-HSIN KUO ; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG Lung Cancer3534
4292006An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancerChao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH ; Kao W.Y.; Chen L.T.; ANN-LII CHENG British Journal of Cancer1313
4302006Differential expression of glucocorticoid receptor in human breast tissues and related neoplasmsHUANG-CHUN LIEN ; YEN-SHEN LU ; ANN-LII CHENG ; Chang W.-C.; YUNG-MING JENG ; Kuo Y.-H.; CHIUN-SHENG HUANG ; KING-JEN CHANG ; Yao Y.-T.Journal of Pathology4948
4312006Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazoneYao C.-J.; Lai G.-M.; Chan C.-F.; ANN-LII CHENG ; Yang Y.-Y.; Chuang S.-E.International Journal of Cancer6767
4322006Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysisCHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; RUEY-LONG HONG ; Chang C.-J.; ANN-LII CHENG Cancer Epidemiology Biomarkers and Prevention6751
4332006Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicityCHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; ANN-LII CHENG ; Chen J.; Vogelzang N.J.; YEONG-SHIAU PU Cancer2424
4342006Primary thyroid lymphoma mimicking subacute thyroiditis [4]Yang Y.-S.; MU-ZON WU ; ANN-LII CHENG ; TIEN-CHUN CHANG Acta Cytologica9
4352006A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleusPei Y.Y.; SUNG-HSIN KUO ; KUN-HUEI YEH ; Chuang S.-E.; CHIH-HUNG HSU ; Wen C.C.; Lin H.-I.; Gao M.; ANN-LII CHENG Journal of Biological Chemistry4339
4362006Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancerCh'ang H.-J.; Wang C.-C.; ANN-LII CHENG ; CHIUN HSU ; YEN-SHEN LU ; MING-CHU CHANG ; Lin J.-T.; HSIU-PO WANG ; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T.Journal of Gastroenterology and Hepatology (Australia)88
4372006Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal originCHING-HUNG LIN ; KUAN-TING KUO ; Chuang S.-S.; SUNG-HSIN KUO ; Chang J.H.; Chang K.-C.; Hsu H.-C.; HWEI-FANG TIEN ; ANN-LII CHENG Clinical Cancer Research11195
4382006Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHaYEN-SHEN LU ; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG Journal of Endocrinology2321
4392006Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphomaTSU-YAO CHENG ; Lin J.-T.; Chen L.-T.; CHIA-TUNG SHUN ; HSIU-PO WANG ; MING-TSAN LIN ; Wang T.-E.; ANN-LII CHENG ; MING-SHIANG WU Journal of Clinical Oncology8372
4402005Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)KUN-HUEI YEH ; SUNG-HSIN KUO ; Chen, Li-Tzong; TSUI-LIEN MAO ; SHIN-LIAN DOONG ; MING-SHIANG WU ; Hsu, Hui-Chen; Tzeng, Yi-Shin; Chen, Chi-Long; JAW-TOWN LIN ; ANN-LII CHENG Blood7159
4412005Identification and characterization of a novel gene Saf transcribed from the opposite strand of FasYan M.-D.; Hong C.-C.; Lai G.-M.; ANN-LII CHENG ; Lin Y.-W.; Chuang S.-E.Human Molecular Genetics8480
4422005Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: Tissue accumulation and the reversibility after washout are tissue-selectiveCHUN-JUNG LIN ; MEI-HWAN WU ; Hsueh Y.-M.; Sun S.S.-M.; ANN-LII CHENG Cancer Chemotherapy and Pharmacology2418
4432005Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family proteinCHIH-HSIN YANG ; Huang C.-J.; Yang C.-S.; Chu Y.-C.; ANN-LII CHENG ; Whang-Peng J.; PAN-CHYR YANG Cancer Research9388
4442005Expression of CD86 and increased inflitration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphomaSUNG-HSIN KUO ; Chen L.-T.; Chen C.-L.; SHIN-LIAN DOONG ; KUN-HUEI YEH ; MING-SHIANG WU ; TSUI-LIEN MAO ; Hsu H.-C.; HSIU-PO WANG ; Lin J.-T.; ANN-LII CHENG World Journal of Gastroenterology1515
4452005Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancerKUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.F.; Chao H.J.; Ta-Chen Huang ; Chung C.Y.; Chang C.S.; CHIH-HSIN YANG ; ANN-LII CHENG British Journal of Cancer77
4462005Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trialsSUNG-HSIN KUO ; CHIH-HSIN YANG ; CHONG-JEN YU ; CHIUN HSU ; ANN-LII CHENG ; PAN-CHYR YANG Lung Cancer77
4472005Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptorsYEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; KUN-HUEI YEH ; Kuo M.-L.; SUNG-HSIN KUO ; ANN-LII CHENG World Journal of Gastroenterology2625
4482005Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysisYing-Chun Shen ; Chang C.-J.; CHIUN HSU ; Cheng C.-C.; Chiu C.-F.; ANN-LII CHENG Cancer Epidemiology Biomarkers and Prevention129116
4492005Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphomaChen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; HSIU-PO WANG ; SUNG-HSIN KUO ; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG Journal of the National Cancer Institute173135
4502005Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patientsSu W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG ; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; YEN-SHEN LU ; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN World Journal of Gastroenterology1814
4512005Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lungKUN-HUEI YEH ; Shiou-Hwei Yeh ; Wan J.-P.; Ying-Chun Shen ; ANN-LII CHENG Anti-Cancer Drugs43
4522005Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factorsCHIUN HSU ; CHIUNG-NIEN CHEN ; Chen L.-T.; Wu C.-Y.; FON-JOU HSIEH ; ANN-LII CHENG Radiology2322
4532005Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatmentCHIH-HSIN YANG ; Chen M.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Yu Y.-C.; Whang-Peng J.; PAN-CHYR YANG Oncology54
4542005Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitroCHIH-HUNG HSU ; Gao M.; Chen C.-L.; Yeh P.-Y.; ANN-LII CHENG Oncology3937
4552005Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancerKUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.-F.; CHIUN HSU ; SUNG-HSIN KUO ; Li Jr. S.; ANN-LII CHENG Oncology2222
4562004Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cellsKUN-HUEI YEH ; ANN-LII CHENG ; Wan J.-P.; Lin C.-S.; Liu C.-C.Anti-Cancer Drugs3733
4572004Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tractCHIUN HSU ; Ying-Chun Shen ; CHIH-HSIN YANG ; KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG British Journal of Cancer4240
4582004Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cellsYEONG-SHIAU PU ; Hour T.-C.; Chuang S.-E.; ANN-LII CHENG ; Lai M.-K.; Kuo M.-L.Prostate7071
4592004Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell linesYing-Chun Shen ; CHIUN HSU ; Chen J.-Y.; ANN-LII CHENG British Journal of Cancer45
4602004Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA PeptidesLiu K.-J.; Wang C.-C.; Chen L.-T.; ANN-LII CHENG ; Lin D.-T.; Wu Y.-C.; Yu W.-L.; Hung Y.-M.; Yang H.-Y.; Juang S.-H.; Whang-Peng J.Clinical Cancer Research8076
4612004Recent advances in therapy for gastric cancerKUN-HUEI YEH ; ANN-LII CHENG Journal of the Formosan Medical Association77
4622004Recent advances in non-surgical treatment for advanced hepatocellular carcinomaCHIUN HSU ; CHIA-HSIEN CHENG ; ANN-LII CHENG Journal of the Formosan Medical Association2318
4632004Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinomaLu Y.-S.; CHIUN HSU ; Li C.-C.; Kuo S.-H.; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIH-HUNG HSU ; Wu C.-Y.; ANN-LII CHENG Hepato-Gastroenterology1413
4642004Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomasSUNG-HSIN KUO ; Chen L.-T.; KUN-HUEI YEH ; MING-SHIANG WU ; Hsu H.-C.; Yeh P.-Y.; TSUI-LIEN MAO ; Chen C.-L.; SHIN-LIAN DOONG ; Lin J.-T.; ANN-LII CHENG Journal of Clinical Oncology6353
4652004Effect of interleukin-1β and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphomaMING-SHIANG WU ; CHIA-TUNG SHUN ; Huang S.-P.; ANN-LII CHENG ; Chen L.-T.; Lin J.-T.Haematologica1816
4662004Promoter polymorphisms of tumor necrosis factor-α are associated with risk of gastric mucosa-associated lymphoid tissue lymphomaMING-SHIANG WU ; Chen L.-T.; CHIA-TUNG SHUN ; Huang S.-P.; HAN-MO CHIU ; HSIU-PO WANG ; MING-TSAN LIN ; ANN-LII CHENG ; Lin J.-T.International Journal of Cancer6054
4672004Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancerChao Y.; KUN-HUEI YEH ; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG British Journal of Cancer7263
4682004Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylationYeh P.Y.; KUN-HUEI YEH ; Chuang S.-E.; Song Y.C.; ANN-LII CHENG Journal of Biological Chemistry9690
4692004Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapyCHIH-HUNG HSU ; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN ; ANN-LII CHENG Anticancer Research4741
4702004Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell deathYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG Oncogene7169
4712003Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphomaANN-LII CHENG ; Hsiung C.A.; Su I.-J.; PEI-JER CHEN ; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J.Hepatology264226
4722003High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine LeiomyosarcomaKUN-HUEI YEH ; YEN-SHEN LU ; Hsiao C.-H.; ANN-LII CHENG Anticancer Research33
4732003Hepatitis B virus X protein activates a survival signaling by linking Src to phosphatidylinositol 3-kinaseShih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG ; SHIN-LIAN DOONG Journal of Biological Chemistry5249
4742003Direct cardiac effects of As2O3 in rabbits: Evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administrationMEI-HWAN WU ; CHUN-JUNG LIN ; Chen C.-L.; MING-JAI SU ; Sun S.S.-M.; ANN-LII CHENG Toxicology and Applied Pharmacology2823
4752003Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of ageJIN-TUNG LIANG ; KUO-CHIN HUANG ; ANN-LII CHENG ; YUNG-MING JENG ; MING-SHIANG WU ; Wang S.M.British Journal of Surgery158140
4762003Low-dose thalidomide treatment for advanced hepatocellular carcinomaCHIUN HSU ; CHIUNG-NIEN CHEN ; Chen L.-T.; Wu C.-Y.; PEI-MING YANG ; Lai M.-Y.; PO-HUANG LEE ; ANN-LII CHENG Oncology8777
4772003Survival-weighted health profile for long-term survivors of acute myelogenous leukemiaCHIUN HSU ; Wang J.-D.; Hwang J.-S.; HWEI-FANG TIEN ; Chang S.-M.; ANN-LII CHENG ; YAO-CHANG CHEN ; JIH-LUH TANG Quality of Life Research2824
4782003Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cellsYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; ANN-LII CHENG Biochemical Pharmacology3731
4792002High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resectionJIN-TUNG LIANG ; KUO-CHIN HUANG ; HONG-SHIEE LAI ; PO-HUANG LEE ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; Tang C.; KING-JEN CHANG International Journal of Cancer10998
4802002Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancerCHIH-HSIN YANG ; PAN-CHYR YANG ; Wang L.S.; Lee Y.C.; CHIEN-JEN CHANG ; Lui L.T.; Yen S.H.; CHIUN HSU ; ANN-LII CHENG ; Liu M.Y.; Chiang S.C.; Chen Y.M.; KWEN-TAY LUH ; Huang M.H.; Yang P.-C.; Perng R.-P.British Journal of Cancer2420
4812002Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatinCHIH-HUNG HSU ; Hergenhahn M.; Chuang S.-E.; Yeh P.-Y.; Wu T.-C.; Gao M.; ANN-LII CHENG Anticancer Research1513
4822002Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cellsChuang S.-E.; Yeh P.-Y.; YEN-SHEN LU ; Lai G.-M.; Liao C.-M.; Gao M.; ANN-LII CHENG Biochemical Pharmacology161138
4832002P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resectionJIN-TUNG LIANG ; KUO-CHIN HUANG ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; KING-JEN CHANG International Journal of Cancer6657
4842002Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapySUNG-HSIN KUO ; LIANG-IN LIN ; Chang C.-J.; Liu Y.-R.; Lin K.-S.; ANN-LII CHENG Journal of Clinical Microbiology2520
4852002Prognostic value of multidrug resistance 1, glutathione-S-transferase-π and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapyCHIH-HUNG HSU ; Chen C.-L.; RUEY-LONG HONG ; Chen K.-L.; Lin J.-F.; ANN-LII CHENG Oncology3125
4862002The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cellsHergenhahn M.; Soto U.; Weninger A.; Polack A.; CHIH-HUNG HSU ; ANN-LII CHENG ; Rösl F.Molecular Carcinogenesis7061
4872002Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinomaCHIUN HSU ; CHIUN-SHENG HUANG ; Chao T.-Y.; YEN-SHEN LU ; Bu C.-F.; Chen M.M.; KING-JEN CHANG ; ANN-LII CHENG Cancer1211
4882002HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivityCHIUN HSU ; Huang C.-L.; Hsu H.-C.; PO-HUANG LEE ; Wang S.-J.; ANN-LII CHENG Cancer4133
4892002Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activationYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; Ea C.-K.; ANN-LII CHENG Biochemical Pharmacology130128
4902002A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracilCHIH-HUNG HSU ; ANN-LII CHENG ; CHIUN HSU ; CHIH-HSIN YANG ; YEN-SHEN LU ; CHIA-CHI LIN ; Bu C.-F.; KUN-HUEI YEH Anticancer Research1212
4912002Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan.CHIH-HUNG HSU ; Chuang S.E.; Hergenhahn M.; Kuo M.L.; Lin J.K.; CHANG-YAO HSIEH ; ANN-LII CHENG Gan to kagaku ryoho. Cancer & chemotherapy130
4922002Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphomaHuang C.-L.; ZHONG-ZHE LIN ; Su I.-J.; Chao T.-Y.; HWEI-FANG TIEN ; Chang M.-C.; Huang M.-C.; Kao W.-Y.; JIH-LUH TANG ; KUN-HUEI YEH ; Wang C.-H.; CHIH-HUNG HSU ; Liu M.-Y.; ANN-LII CHENG Leukemia and Lymphoma95
4932001A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancerCHIA-CHI LIN ; CHIH-HUNG HSU ; Chen J.; Tsai T.-C.; ANN-LII CHENG ; YEONG-SHIAU PU Anticancer Research1413
4942001Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomachChen L.-T.; Lin J.-T.; Shyu R.-Y.; Jan C.-M.; Chen C.-L.; Chiang I.-P.; Liu S.-M.; Su I.-J.; ANN-LII CHENG Journal of Clinical Oncology9576
4952001Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicinYeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Chyi Song Y.; ANN-LII CHENG Biochemical and Biophysical Research Communications3435
4962001Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: Does histologic evidence of MALT affect chemotherapy response?CHIUN HSU ; Chen C.-L.; Chen L.-T.; Liu H.-T.; YAO-CHANG CHEN ; Jan C.-M.; Liu C.-S.; ANN-LII CHENG Cancer14
4972001Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinomaCHIH-HUNG HSU ; Chen J.; Wu C.-Y.; ANN-LII CHENG ; YEONG-SHIAU PU Anticancer Research2724
4982001Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesionsANN-LII CHENG ; CHIH-HUNG HSU ; Lin J.-K.; Hsu M.-M.; YUNN-FANG HO ; She T.-S.; JENG-YUH KO ; Lin J.-T.; BOR-RU LIN ; MING-SHIANG WU ; Yu H.-S.; SHIOU-HWA JEE ; Chen G.-S.; Chen T.-M.; CHI-AN CHEN ; Lai M.-K.; YEONG-SHIAU PU ; MIN-HSIUNG PAN ; Wang Y.-J.; Tsai C.-C.; CHANG-YAO HSIEH Anticancer Research19251695
4992000Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracilKUN-HUEI YEH ; Shiou-Hwei Yeh ; CHIH-HUNG HSU ; TONG-MEI WANG ; Ma I.-F.; ANN-LII CHENG British Journal of Cancer26
5002000Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in ratsChuang S.-E.; ANN-LII CHENG ; Lin J.-K.; Kuo M.-L.Food and Chemical Toxicology181151
5012000Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functionsWang K.-C.; ANN-LII CHENG ; Chuang S.-E.; Hsu H.-C.; Su I.-J.Experimental Hematology2623
5022000Metaplastic carcinoma of the breast-analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancerSUNG-HSIN KUO ; Chen C.-L.; CHIUN-SHENG HUANG ; ANN-LII CHENG Anticancer Research3128
5032000Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxelCHIH-HUNG HSU ; Chen M.-Y.; ANN-LII CHENG Anticancer Research64
5042000Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: Direct evidence from colony forming unit- granulocyte and monocyte (CFU-GM) clonogenic assayKUN-HUEI YEH ; Shiou-Hwei Yeh ; Chang Y.-S.; ANN-LII CHENG Pharmacology and Toxicology1512
5052000Chemotherapy alone versus, surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomachLiu H.-T.; CHIUN HSU ; Chen C.-L.; Chiang I.-P.; Chen L.-T.; YAO-CHANG CHEN ; ANN-LII CHENG American Journal of Hematology34
5062000Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesisChuang S.E.; Kuo M.L.; CHIH-HUNG HSU ; Chen C.R.; Lin J.K.; Lai G.M.; CHANG-YAO HSIEH ; ANN-LII CHENG Carcinogenesis240210
5072000Hepatitis b virus x protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathwayShih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG ; SHIN-LIAN DOONG Journal of Biological Chemistry174163
5081999Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphomaKUN-HUEI YEH ; HUANG-CHUN LIEN ; Hsu S.-M.; ANN-LII CHENG American Journal of Hematology31
5091999Hypermethylation of the p16 gene in sporadic T3NOMO stage colorectal cancers: Association with DNA replication error and shorter survivalJIN-TUNG LIANG ; KING-JEN CHANG ; Chen J.-C.; Lee C.-C.; Cheng Y.-M.; Hsu H.-C.; MING-SHIANG WU ; Wang S.-M.; Lin J.-T.; ANN-LII CHENG Oncology7870
5101999The significance of body weight change in non-Hodgkins lymphomaChin Y.H.; Liu J.M.; Tai J.J.; Chuang M.S.; Ho Y.L.; Chen Y.M.; Whang-Peng J.; ANN-LII CHENG Anticancer Research43
5111999Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracilCHIH-HUNG HSU ; KUN-HUEI YEH ; Lui L.T.; Lee Y.-C.; Bu C.-F.; HSIU-PO WANG ; Lin J.-T.; ANN-LII CHENG Anticancer Research2926
5121999Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapyKUN-HUEI YEH ; CHIA-TUNG SHUN ; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG Hepato-Gastroenterology2324
5131999High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinomaCHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHONG-JEN YU ; Lin J.-F.; PAN-CHYR YANG Cancer23
5141998Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocolANN-LII CHENG ; KUN-HUEI YEH ; Uen W.-C.; Hung R.-L.; Liu M.-Y.; Wang C.-H.Cancer61
5151998Transactivation of the human MDR1 gene by hepatitis B virus X gene productSHIN-LIAN DOONG ; Lin M.-H.; Tsai M.-M.; Li T.-R.; Chuang S.-E.; ANN-LII CHENG Journal of Hepatology1211
5161998High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapyKUN-HUEI YEH ; CHIA-TUNG SHUN ; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG Cancer105
5171998Gastric cancer associated with acute disseminated intravascular coagulation: Successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorinKUN-HUEI YEH ; ANN-LII CHENG British Journal of Haematology4035
5181998Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifenANN-LII CHENG ; Chuang S.-E.; Fine R.L.; KUN-HUEI YEH ; Liao C.-M.; Lay J.-D.; Chen D.-S.Biochemical Pharmacology6965
5191998Encephalopathy, lactic acidosis, hyperammonaemia and 5-fluorouracil toxicity (multiple letters) [1]Valik D.; KUN-HUEI YEH ; ANN-LII CHENG British Journal of Cancer35
5201998Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancerKUN-HUEI YEH ; YAO-CHANG CHEN ; Shiou-Hwei Yeh ; Chen C.-P.; Lin J.-T.; ANN-LII CHENG Anticancer Research4643
5211998Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suraminHutson P.R.; Tutsch R.D.; Rago R.; Arzoomanian R.; Alberti D.; Pomplun M.; Church D.; Marnocha R.; ANN-LII CHENG ; Kehrli N.; Wilding G.Clinical Cancer Research99
5221998Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinomaANN-LII CHENG ; KUN-HUEI YEH ; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; DING-SHINN CHEN Hepato-Gastroenterology4133
5231998High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancersKUN-HUEI YEH ; Lin M.-T.; Lin D.-T.; JIH-LUH TANG ; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG ; Yu S.-C.; KING-JEN CHANG ; YAO-CHANG CHEN Breast Cancer Research and Treatment22
5241998Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancersKUN-HUEI YEH ; Chen C.-L.; CHIA-TUNG SHUN ; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG Journal of Clinical Gastroenterology1512
5251998Research nurses for clinical trials of anti-cancer drugs: Developing a new subspecialty in TaiwanANN-LII CHENG ; YEUR-HUR LAI ; Yu Y.-C.Drug Information Journal00
5261998Megestrol acetate antagonizes cisplatin cytotoxicityYEONG-SHIAU PU ; ANN-LII CHENG ; Chen J.; Guan J.-Y.; Lu S.-H.; Lai M.-K.; CHANG-YAO HSIEH Anti-Cancer Drugs33
5271998Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activityKuo M.-L.; Shen S.-C.; CHIH-HSIN YANG ; Chuang S.-E.; ANN-LII CHENG ; Huang T.-S.Oncogene3935
5281998Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancerANN-LII CHENG ; KUN-HUEI YEH ; Lin J.-T.; CHIUN HSU ; Liu M.-Y.Anticancer Research2320
5291997Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: Clinical correlationChou Y.-Y.; ANN-LII CHENG ; Hsu H.-C.Journal of Gastroenterology and Hepatology (Australia)4341
5301997Transforming growth factor β1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cellsKuo M.-L.; Chen C.-W.; SHIOU-HWA JEE ; Chuang S.-E.; ANN-LII CHENG Biochemical Journal1819
5311997MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancerCHIUN HSU ; KUN-HUEI YEH ; RUEY-LONG HONG ; CHIH-HSIN YANG ; Lin M.-T.; YAO-CHANG CHEN ; ANN-LII CHENG Journal of the Formosan Medical Association43
5321997A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancersKUN-HUEI YEH ; ANN-LII CHENG ; Lin M.-T.; RUEY-LONG HONG ; CHIH-HUNG HSU ; Lin J.-F.; KING-JEN CHANG ; PO-HUANG LEE ; YAO-CHANG CHEN Anticancer Research3227
5331997Angioimmunoblastic lymphadenopathy with dysproteinemia - lack of a prognostic value of clear cell morphologyCh’ang H.-J.; Su I.J.; Chen C.L.; Zmija I.P.; YAO-CHANG CHEN ; Wang C.H.; ANN-LII CHENG Oncology (Switzerland)77
5341997Weekly CAF chemotherapy for advanced breast cancer patientsHwang W.-S.; Hsiung C.A.; Ko W.-S.; lVang C.-C.; Chang J.-V.; Lai G.-M.; Hsieh R.-K.; Tsao C.-J.; Chen L.-T.; Law C.-K.; ANN-LII CHENG ; Fan S.F.; Tzeng C.-H.; Chiou T.-J.; Whang-Peng J.Oncology (Switzerland)11
5351997Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instabilityMING-SHIANG WU ; JIN-CHUAN SHEU; CHIA-TUNG SHUN ; Lee W.-J.; JIN-TOWN WANG ; Wang T.-H.; ANN-LII CHENG ; Lin J.-T.Cancer Letters3129
5361997Thymic carcinoma with autoimmune syndrome: Successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorinCHIH-HUNG HSU ; KUN-HUEI YEH ; ANN-LII CHENG Anticancer Research1817
5371997High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy [2]KUN-HUEI YEH ; ANN-LII CHENG British Journal of Cancer12497
5381997Stability of curcumin in buffer solutions and characterization of its degradation productsWang Y.-J.; Pan M.-H.; ANN-LII CHENG ; LIANG-IN LIN ; Ho Y.-S.; CHANG-YAO HSIEH ; Lin J.-K.Journal of Pharmaceutical and Biomedical Analysis14521302
5391997Early gastric cancer as a possible cause of cauda equina syndrome and disseminated intravascular coagulationSHU-CHEN WEI ; Wong J.-M.; Chen C.-L.; ANN-LII CHENG ; Wang C.-Y.; Wang T.-H.Digestive Endoscopy00
5401997High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lungKUN-HUEI YEH ; ANN-LII CHENG Anticancer Research1411
5411997Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancersCHIH-HUNG HSU ; KUN-HUEI YEH ; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; YAO-CHANG CHEN ; ANN-LII CHENG Oncology (Switzerland)6051
5421997Prognostic significance of immunophenotypes in adult lymphoblastic lymphomasKUN-HUEI YEH ; ANN-LII CHENG ; Su I.H.-J.; Lin M.-T.; HWEI-FANG TIEN ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN Anticancer Research2014
5431997Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomasANN-LII CHENG ; Chuang S.-E.; Su I.-J.Journal of the Formosan Medical Association109
5441997Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 geneChuang S.-E.; SHIN-LIAN DOONG ; Lin M.-T.; ANN-LII CHENG Biochemical and Biophysical Research Communications810
5451996Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma [3]ANN-LII CHENG Blood7159
5461996Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: Clinicopathologic analysis of 19 casesChiang I.-P.; Wang H.-H.; ANN-LII CHENG ; Lin J.-T.; Su I.-J.Journal of the Formosan Medical Association99
5471996Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: A potential use in intravesical chemotherapyYEONG-SHIAU PU ; Hsieh T.-S.; ANN-LII CHENG ; Tseng N.-F.; Su I.-J.; CHANG-YAO HSIEH ; Lai M.-K.; Tsai T.-C.British Journal of Urology2221
5481996Expression of mdr-1 gene in transitional cell carcinoma and its correlation with chemotherapy responseYEONG-SHIAU PU ; Tsai T.-C.; ANN-LII CHENG ; Tsai C.-Y.; Tseng N.-F.; Su I.H.-J.; CHANG-YAO HSIEH ; Lai M.-K.Journal of Urology2625
5491996Polyprenoic acid in hepatocellular carcinomaCHIH-HSIN YANG ; ANN-LII CHENG New England Journal of Medicine00
5501996Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinomaANN-LII CHENG ; YAO-CHANG CHEN ; KUN-HUEI YEH ; Chuang S.-E.; Chen B.-R.; DING-SHINN CHEN Cancer37
5511996Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: Special emphasis on the tumor response to 13-cis retinoic acidWEN-CHIEN CHOU ; Su I.-J.; HWEI-FANG TIEN ; Liang D.-C.; Wang C.-H.; Chang Y.-C.; ANN-LII CHENG Cancer43
5521995Single-step direct cloning of PCR productsChuang S.-E.; Wang K.-C.; ANN-LII CHENG Trends in Genetics42
5531995Hemophagocytic syndrome in epstein-Barr virus-associated t-lymphoproliferative disorders: Disease spectrum, pathogenesis, and managementSu I.-J.; Wang C.-H.; ANN-LII CHENG ; Chen R.-L.Leukemia and Lymphoma124101
5541995Growth of E.coli at low temperature dramatically increases the transformation frequency by electroporationChuang S.-E.; ANN-LII CHENG ; Chao C.-C.Nucleic Acids Research2019
5551995Clinicopathologic characteristics of helicobacter pyloric seropositive gastric adenocarcinomasLee W.-J.; Lin J.-T.; WEN-CHUNG LEE ; CHIA-TUNG SHUN ; RUEY-LONG HONG ; ANN-LII CHENG ; PO-HUANG LEE ; Wei T.-C.; Chen K.-M.Journal of Clinical Gastroenterology1313
5561995Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma CellsYEONG-SHIAU PU ; Hsieh T.-S.; Tsai T.-C.; ANN-LII CHENG ; CHANG-YAO HSIEH ; Su I.-J.; Lai M.-K.The Journal of Urology3530
5571995Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapyKUN-HUEI YEH ; ANN-LII CHENG ; HWEI-FANG TIEN Oncology (Switzerland)149
5581994Characteristic clinicopathologic features of adult B‐cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation originANN-LII CHENG ; Su I.‐J.; HWEI-FANG TIEN ; Wang C.‐C.; YAO-CHANG CHEN ; Wang C.‐H.Cancer18
5591994An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin [2]KUN-HUEI YEH ; ANN-LII CHENG Journal of Clinical Oncology1816
5601994Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acidKUN-HUEI YEH ; ANN-LII CHENG Journal of the Formosan Medical Association160
5611994Modulation of retinoic acid receptor alpha, growth factor and proto-oncogenes in retinoic acid-induced apoptosis of Ki-1 lymphoma cell lineSu I.-J.; Lay Z.-D.; ANN-LII CHENG ; Chang Y.-C.International Journal of Oncology6
5621994Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphomaMING YAO ; ANN-LII CHENG ; Su I.-J.; Lin M.-T.; Uen W.-C.; HWEI-FANG TIEN ; Wang C.-H.; YAO-CHANG CHEN British Journal of Haematology8166
5631994Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: A pilot studyKUN-HUEI YEH ; ANN-LII CHENG ; Chen Y.-C.; Chen B.-R.; Lee W.-J.; Lin J.-T.; PO-HUANG LEE ; KING-JEN CHANG ; Wang C.-H.; Wang T.-H.Journal of the Formosan Medical Association60
5641994Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot studyANN-LII CHENG ; Su I.-J.; Chen C.-C.; HWEI-FANG TIEN ; Lay J.-D.; Chen B.-R.; YEONG-SHIAU PU ; RUEY-LONG HONG ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN Journal of Clinical Oncology5046
5651993Cutaneous manifestations of Epstein-Barr virus—associated T-cell lymphomaSu I.-J.; TSEN-FANG TSAI ; ANN-LII CHENG ; Chen C.-C.Journal of the American Academy of Dermatology6457
5661993Epstein—barr virus‐containing t‐cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosisSu I.J.; Hsu Y.H.; Lin M.T.; ANN-LII CHENG ; Wang C.H.; Weiss L.M.Cancer82
5671993Characteristic clinicopathologic features of epstein-barr virus—associated peripheral T-cell lymphomaANN-LII CHENG ; Ih-Jen Su; YAO-CHANG CHEN ; Wu-Ching Uen; Chiu-Hwa WangCancer82
5681993Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: The possible role of epstein-barr virus, immunophenotypes, and other predisposing factorsANN-LII CHENG ; Su I.-J.; YAO-CHANG CHEN ; Lee T.-C.; Wang C.-H.Journal of Clinical Oncology7879
5691993Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multi-drug-resistance phenotypesSu I.?J.; ANN-LII CHENG ; TSEN-FANG TSAI ; Lay J.?D.British Journal of Haematology1715
5701992Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virusTSEN-FANG TSAI ; Su I.-J.; Lu Y.-C.; ANN-LII CHENG ; Yeh H.-P.; Hsieh H.-C.; HWEI-FANG TIEN ; JAU-SHIUH CHEN ; Uen W.-C.Journal of the American Academy of Dermatology5754
5711992Present status of cancer treatment in TaiwanHow S.-W.; ANN-LII CHENG Japanese Journal of Cancer and Chemotherapy00
572199113-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphomaChow J.M.; ANN-LII CHENG ; Su I.J.; Wang C.H.Cancer22
5731991Expression of growth-related genes and drug-resistance genes in HTLV-I-positive and HTLV-I-negative post-thymic T-cell malignanciesSu I.-J.; Chang I.-C.; ANN-LII CHENG Annals of Oncology1614
5741991Menadione: Spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell linesNutter L.M.; ANN-LII CHENG ; Hsiao-Ling H.; Ruey-Kun H.; Ngo E.O.; Tsang-Wu L.Biochemical Pharmacology120122
5751991Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysisSu I.-J.; Hsieh H.-C.; KAI-HSIN LIN ; Uen W.-C.; CHUAN-LIANG KAO ; Chen C.-J.; ANN-LII CHENG ; Kadin M.E.; Chen J.-Y.Blood261270
5761991Disruption of Cellular Energy Balance by Suramin in Intact Human Prostatic Carcinoma Cells, a Likely Antiproliferative MechanismRago R.; Mitchen J.; ANN-LII CHENG ; Oberley T.; Wilding G.Cancer Research4142
5771991Menadione-induced DNA damage in a human tumor cell lineNgo E.O.; Sun T.-P.; Chang J.-Y.; Wang C.-C.; Chi K.-H.; ANN-LII CHENG ; Nutter L.M.Biochemical Pharmacology7075
5781990Cutaneous manifestations of postthymic T cell malignancies: Description of five clinicopathologic subtypesSu I.-J.; Wu Y.-C.; YAO-CHANG CHEN ; Hsieh H.-C.; ANN-LII CHENG ; Wang C.-H.; Kadin M.E.Journal of the American Academy of Dermatology3935
5791989Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - Should peripheral T-cell lymphoma be considered separately?ANN-LII CHENG ; YAO-CHANG CHEN ; Wang C.-H.; Su I.-J.; Hsieh H.-C.; Chang J.-Y.; Hwang W.-S.; Su W.-C.; Liu T.-W.; HWEI-FANG TIEN ; Tsai W.; MING-CHING SHEN ; Liu C.-H.Journal of Clinical Oncology7165
5801989Bone marrow involvement in non-Hodgkin's lymphoma.HONG-SHIEE LAI ; HWEI-FANG TIEN ; Hsieh H.C.; YAO-CHANG CHEN ; Su I.J.; Wang C.H.; Liu M.C.; ANN-LII CHENG ; MING-CHING SHEN ; Liu C.H.Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association110
5811989Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classificationANN-LII CHENG ; YAO-CHANG CHEN ; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; HONG-SHIEE LAI ; Liu T.-W.; HWEI-FANG TIEN ; MING-CHING SHEN ; Liu C.-H.Journal of the Formosan Medical Association130
5821988Characterization of the spectrum of postthymic T‐cell malignancies in Taiwan a clinicopathologic study of HTLV‐1‐positive and HTLV‐1‐negative casesSu I.-J.; Wang C.-H.; ANN-LII CHENG ; YAO-CHANG CHEN ; Hsieh H.-C.; HWEI-FANG TIEN ; Huang S.-S.; CHUNG-YI HU ; PEI-JER CHEN ; Chen J.-Y.; Hsu H.-C.; Chuang S.-M.; MING-CHING SHEN ; Kadin M.E.Cancer45
5831987Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary reportYAO-CHANG CHEN ; Wang C.H.; Lin D.T.; Lui P.T.; ANN-LII CHENG ; Liu T.W.; WOEI TSAY ; HWEI-FANG TIEN ; Liu M.C.; Chuu W.M.Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association00
5841986Adult acute lymphoblastic leukemia--lineage specific classification of 30 cases.ANN-LII CHENG ; YAO-CHANG CHEN ; Wang C.H.; MING-CHING SHEN ; Hsieh R.P.; HWEI-FANG TIEN ; Liu M.C.; HONG-SHIEE LAI ; Liu C.H.Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association00